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Abstract

THE EFFECT OF DIETARY FAT LEVEL ON TUMOR DEVELOPMENT AND IMMUNITY
IN BALB/C MICE FED CASEIN OR WHEAT GLUTEN AS PROTEIN
AND CHALLENGED WITH HERPES TYPE 2-TRANSFORMED CELLS

by Helen Drakou

A high percentage of fat in the diet has been implicated through
epidemiological studies in several human cancers.

Studies in

experimental animals have produced evidence that increasing the fat in
the diet decreases the animal’s ability to restrict tumor development
and growth.

In previous work done in this laboratory with BALB/c mice

injected with herpes simplex Type 2-transformed mouse cells (H238), the
effects of a diet which greatly enhanced tumor growth was compared with
one which restricted tumor growth.

The latter, a low (5%) fat, low

protein diet, in which the protein was casein, was also found to produce
a higher cell mediated immunity than the former, a high (30%) fat, low
protein diet in which the protein was wheat gluten. The present research
was designed to determine to what extent the level of fat and to what
extent the source of protein were factors in tumor development and to
determine relationships of these with cell-mediated immunity.

Secondly,

the four diets used were all designed to be equal with respect to
nutrient (protein, fiber, each individual vitamin, each individual
mineral) to calorie ratios.

Four diets were used in the study: the two diets mentioned
previously (Diet 1 and Diet 4 respectively), and two control diets,

One

of the latter was a high (30%) fat, low (11%) protein diet in which the
protein was casein (Diet 3); the other was a low (5%) fat, low (11%)
protein diet in which the protein was wheat gluten (Diet 2). The mice
were fed for 10 weeks (Diets 1 and 3) or for 20 weeks (Diets 2 and 4)
before injection of the tumor cells.

Non-injected mice served as

the controls.

Tumor volume measurements were made once or twice a week.

At

euthanization each mouse and its spleen were weighed and relative spleen
weights were calculated.

The spleen cells were used in a microculture

lymphocyte transformation test (LTT) using phytohemagglutinin (PHA),
concanavalin A (ConA) or lipopolysaccharide (LPS) as mitogens.

The type of protein present in the diets of the mice (casein or
wheat gluten) appeared to be the most important factor influencing tumor
development.

Mice fed the 11% casein had the lowest tumor volumes and

higher mean counts per minute values (when treated with PHA, ConA or
LPS) as long as the level of fat was also low (5% corn oil).

In

contrast, mice fed the 11% protein-wheat gluten, 30% fat developed
significantly greater tumor volumes throughout the study (compared to
mice fed the 11% wheat gluten, 5% fat diet) and depressed lymphoproliferative responses to mitogenic stimulation.
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INTRODUCTION

During the past two decades, increasing attention has been given to
the role of diet and its influence on the development of certain forms
of cancer.

Epidemiological surveys indicate that diet may be associated

with 60% of all cancers in women and 40% in men (Wynder, 1975). Diet
probably does not lead directly to tumor development and growth but a
relationship exists between high incidences of tumors of the esophagus.
stomach, colon, breast, liver, skin and specific dietary components such
as fat.

Intrinsic factors as well as the environment and the diet can all
contribute to the changes that cause a normal cell to become a malignant
one.

It has been reported that up to 35% of all cancers may be

prevented by changing dietary habits (Newell, 1983).

Of all the dietary components studied, the combined epidemiological
and experimental evidence is most suggestive for a relationship between
fat intake and occurrence of cancer at a selected site (Reddy, 1980;
Locniskar et al., 1983).

In an attempt to better understand the complex

role of dietary fat in tumor development and growth, some of the animal
studies which show a direct relationship between dietary fat and cancer

1
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will be presented.

In addition, some of the possible mechanisms by

which dietary fat may enhance tumorigenesis will be discussed.

In the 1930’s, Watson and Mellanby observed that after several
applications of coal tar to mouse skin, an increase in skin tumor
incidence was noted when the mouse diet was supplemented with
12.5 - 25% butter.

Bauman and Rusch (1939) as well as Lavik and Bauman

(1943) showed that dietary fat enhanced the incidence of skin cancer
after exposure to ultraviolet light.

Boutwell et al. (1949) suggested

that the differences in calories (net energy) between low-and high-fat
diets was responsible for the increases in skin tumor incidence.

The

source or saturation of the fat in addition to caloric intake is well
documented by several authors to have an effect on tumor growth (Hopkins
et al., 1979; Ossman et al., 1980; Cross et al., 1980; Good, 1981;
Newberne et al., 1981).

Investigators believe that diets high in polyunsaturated fats are
more immunosuppressive and greater promoters of tumor growth than diets
high in saturated fats (Reddy et al., 1975; Rogers and Newberne, 1975;
Erickson et al., 1980; Locniskar et al., 1983).

High levels of

polyunsaturated fats have been shown to decrease rejection of skin
grafts in animals and suppress delayed hypersensitivity reactions in
both humans and animals (Mertin et al., 1976; De Wille et al., 1981;
Erickson, 1984).

Furthermore, polyunsaturated fats inhibit the lympho-

cyte response to mitogenic stimulation and depress reticuloendothelial
cell function (Kollmorgen et al., 1979; De Wille et al.,1981; Erickson

3
et al., 1983, 1984a).

On the other hand, high levels of saturated fats

are associated with decreased resistance to infection, transplantable
tumors, and host response to foreign antigens (Carroll, 1979; Erickson,
1980, 1983).

In examining any characteristic differences in the effects of
saturated and unsaturated fatty acids on the immune system, Erickson and
his associates (1980) used newborn mice.
levels of either type of fat.

The animals were fed high

Those receiving polyunsaturated fats had

more serum immunoglobulins, particularly IgG (not IgM or IgA), than
those fed saturated fat, which had a decreased number of B-cells
(Erickson et al., 1980).

The same group reported that high levels of

both kinds of fatty acids decreased T-cell blastogenesis (Ossman et al.,
1980; Erickson et al., 1984a, 1984b).

Based on the reports of other

investigators, however, a balance of saturated and unsaturated fatty
acids is important for normal blastogenic response.

(Mandel et al.,

1978).

Carroll et al. (1979) reported that human peripheral lymphocytes
cultured in the presence of saturated (palmitate, stearate) or
unsaturated (oleate, linoleate, arachidonate) fatty acids bound to
albumin (as they are in normal serum) had decreased mitogenic responses.
However, when these fatty acids were both present at the same time.
mitogenic inhibition was less noticeable or non-existent (Hillyard and
Abraham, 1979) Even in the presence of very high levels of fatty acids.
mitogenic inhibition was prevented when a balance existed between these

4
two lipids (Salenskas et al., 1984; Erickson et al., 1984a, 1984b).

Several scientists speculated that these reports probably reflect
the need for an appropriate concentration of saturated and unsaturated
fatty acids in the lymphocyte cell membrane (Burns et al., 1979; Stubbs
et al., 1980; Adams and Erickson, 1985).

Extensive laboratory studies have shown that animals fed a high fat
diet developed more intestinal tumors and more metastases than the
animals fed a low fat diet (Nigro et al., 1975; Reddy et al., 1975,
1976, 1977a, 1977b).

Further studies, using an animal model, suggest

that colon tumor promotion results through a mechanism involving
increased bile acid secretion (Bull et al., 1979).

Colonic bile acids

and their metabolites act as possible tumor-promoting agents in colon
cancer (Reddy and Watanabe, 1979). Other studies also indicate that a
high intake of dietary fiber, in spite of high dietary fat, not only
influences bile acid metabolism, by reducing the formation of tumor
promoting substances in colon carcinogenesis, but also acts as a
solvent.

It dilutes potential carcinogens and/or cocarcinogens by its

ability to bind water, sterols, bile acids and fats (Kritchevsky and
Story, 1974; Story and Kritchevsky, 1978; Kay, 1978).

Additional studies have suggested that the protective effect of
dietary fiber in colon carcinogenesis is probably at the promotional
stage rather than at the initiating period (Bauer et al., 1979; Watanabe
et al., 1979; Nigro et al., 1979).

5
Studies have also been done in regard to dietary fat intake and
Welsch et al. (1977) suggested that hormones such

cancer of the breast.

as prolactin, estrogen, and progesterone, which control the growth of
breast tissue, may be involved in the process of mammary tumor
development and growth.

However, conflicting reports indicate that high

concentrations of dietary fat either increase or have no effect on
rodent serum prolactin or estrogen levels (Giovarelli et al., 1980;
Cohen et al., 1981).

Thus, hormones such as prolactin may not play an

essential role in the growth of mammary gland tumors, although prolactin
has been shown to have some activity in the early stages of human and
rat mammary tumorigenesis (Rose, 1979; Reddy, 1980; Hill et al., 1981).
Furthermore, Knazek and Liu (1981) theorized that dietary fat may modify
the action of these hormones on the breast tissue by influencing the
number of the receptors and/or their function.

Additional studies

showed that changes in dietary fat level may alter the concentrations of
plasma steroid hormones.

However, it is not clear how these changes may

be related to mammary tumor growth (Cohen et al., 1981).

Besides influencing the availability of membrane receptors, high
levels of dietary fat intake can affect antigenic expression, and
cellular metabolism (Kidwell et al.,1978; Wicha et al., 1980).

In

addition, Trosko et al. (1982) reported that high levels of dietary fat
may promote mammary carcinogenesis by inhibiting cell-to-cell communi
cation.

Lymphocytes may also be influenced by dietary fat (Erickson et al.,
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1980).

High concentrations of polyunsaturated fat suppressed the

lymphocyte-mediated killing of tumor cells (Abraham and Hillyard, 1983;
Erickson, 1984 ) .

Although investigators have hypothesized that fatty

acids affect the fluid state of the tumor cell membrane and, therefore.
influence the susceptibility of the cell to lysis (Schlager and Ohanian,
1979; Yoo et al., 1980; Adams et al., 1984, 1985), Thomas and Erickson
(1985) demonstrated that the influence of dietary lipid was on the
lymphocyte and not the tumor target cell in both complement-mediated and
cell-mediated lysis of tumor cells.

There are numerous references in the literature on relationships
between tumor growth and immune function.

They are so abundant that a

new branch of immunology has come to be established and to be named
tumor immunology.

Only a few pertinent references, however, will be

discussed in the paragraphs which follow, especially those which deal
with methods for measuring immunity.

Immune System and Tumor Growth

There is evidence that dietary factors can influence immune
responses (Cooper et al., 1974; Faulk et al., 1974).

Cell-mediated

immunity (CMI) is especially of interest because it is believed to be
intimately involved with natural defenses against tumor development and
growth (Blasecki and Tevethia, 1975; Dean et al., 1975; Knight and
Gorczynski, 1975; Ting et al., 1976a, 1976b).
thymus-dependent lymphocytes (T-cells) .

It is associated with
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Cell-mediated immunity can be evaluated by a number of in vitro
methods.

The degree of lymphocyte transformation induced by certain

mitogens has been associated with the in vivo status of the immune
system (Nowell, 1960; Oppenheim and Perry, 1965; Tursi et al., 1969;
Fournier et al.. 1981; Thoman et al., 1982).

Nowell in 1960 and later

Hirschhorn (1968) and others defined lymphocyte transformation as the
morphological change of small lymphocytes to larger lymphoblasts in
vitro.

There are times where only a lymphoproliferation test can detect

defects in cell-mediated immunity (CMI) and the function of the rest of
the immune system (Biberfield et al., 1974; Oppenheim et al., 1975;
Oppenheim and Schecter, 1976).

Specifically, the assay provides:

A) a very useful means of

evaluating immunological competence in genetic and acquired
immunodeficiency states, and B) a sensitive tool for detecting
immunological reactions to pathogens, allergens, and self-antigens
(Catalona et al., 1975; Catanzaro et al., 1975).

However, there are many disadvantages associated with this assay.
Even under optimal experimental conditions, there is considerable
variability in the lymphoproliferative responses of tested individuals.
In addition, the degree of reactivity of the same individual varies to a
great extent upon repeated testing.

Some of this is due to unavoidable

variations in tissue culture techniques, and some is due to
uncontrollable environmental influences on the lymhocyte transformation
assay (Oppenheim et

al., 1970; Foad et al., 1974; Delespesse et al.,

8

1974; Liegler et al., 1975).

Another aspect of the immune response involves humoral immunity.
Bursa-equivalent lymphocytes (B-cells) are primarily associated with
humoral immunity.

Although not considered as a major defense against

tumors, they are capable of producing antibodies which can result in
cytotoxic activities against tumor cells (Boyle et al., 1976; Pilch and
Golub, 1976).

Blocking antibody, which may prevent access of T-cells

and macrophages to the tumor cells, is a B-cell derived antibody
(Hellstrom and Hellstrom, 1976; Ran et al. 1976).

Therefore, during

lymphocyte transformation assays, methods for evaluating B-cell
functions are also included (Wedner et al., 1976; Fauci et al., 1983).

A number of plant lectins and other substances have been used in
evaluating'human and animal lymphocyte functions.

One of the most

widely used lectins in lymphocyte transformation assays is Phytohemagglutinin (PHA).

It is a glycoprotein usually derived from the extracts

of Phaseolus vulgaris (kidney bean).

Initially, PHA was used to

agglutinate Red blood cells (RBC's) during preparation of anti-hog
cholera serum and for the separation of leukocytes from erythrocytes (Li
and Osgood, 1949; Rigas et al.. 1955; Elves and Wilkinson, 1962).

PHA’s

mitogenic properties on T-cells were first brought to attention by
Nowell in 1960.

Since then, several authors suggested that PHA has an

effect on the cell membrane, possibly by binding to mucoprotein groups
on it (Vassar and Culling, 1964;

Lindahl-Kiessling and Peterson, 1967).

This binding causes a sequence of changes leading to production of new
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RNA, protein, and DNA synthesis. The production of DNA results in the
transformation of lymphocytes into large, blastoid-like cells, and
eventually to cell division (Hirschhornk, 1968;

Kurnick et

al., 1976).

Other mitogens useful in detecting lymphocyte responses include:
A) Concanavalin A (Con A), a lectin derived from extracts of Canavalis
It

ensiformis (Jack bean) which is primarily mitogenic for T-cells.

activates many of the same lymphocytes as PHA, but it has a greater
specificity of action on T-suppressor, and T-cytotoxic lymphocytes (Shou
et al. , 1976; Waldmann and Broder, 1977 ; Tsuyoshi and Green, 1977; Knapp
and Posch, 1980), B) endotoxins such as Lipopolysaccharide (LPS),
obtained from the cell walls of certain Gram-negative bacteria; it
stimulates B-cells (Gery et al., 1972; Greaves et al., 1974).

The

mechanisms of action of these mitogens are thought to be similar to that
of PHA.

La Grange et al. (1975) reported that the presence of T-cells

is also essential for the mitogenic effect of LPS on B-cells.
Furthermore, the dose of the mitogen and the time at which it was added
are important variables in this assay (Rich and Pierce, 1973; Todakuma
et al., 1976).

For these reasons, optimum testing conditions should be

determined prior to the application of mitogen-induced lymphoproliferation assay to a given experiment.

Experimental studies in the subject area of diet and cancer have
been performed with both humans and with experimental animals.

Those

dealing with human subjects have been largely epidemiological due to the
difficulties inherent in experimental studies in the field of human

10
cancer.

Tumor studies in experimental animals have been used, however.

to test hypotheses created as a result of the human epidemiological
studies.

In these animal experiments a variety of animal-tumor models

have been used.

Some have been chemically-induced tumors and some have

been virally-induced.

In addition, some have been spontaneous whereas

others have been transplantable.

In the next section, characteristics

of the animal-tumor model used in the present experiments are discussed.

11
Significance of the Herpes Simplex Virus 1_ - Transformed Murine Cell
System

Viruses have been associated with malignancy in a variety of animal
tumor models.

In the beginning of the century (1908) Ellerman and Bang

demonstrated that leukemia in chickens was caused by a filterable agent;
shortly after, Rous (1911) proved that a malignant chicken sarcoma is
caused by a virus.

Following these discoveries several investigators

have reported different virus-induced tumors in animals (Shope, 1933;
Bittner, 1942; Gross, 1951; Friend, 1959).

Several viruses have been found to be associated with specific
human cancers.

There is a strong seroepidemiological evidence

indicating that herpes simplex virus Type 2 (HSV-2) is involved in
cervical carcinoma (Rawls et al., 1968, 1972, 1976; Adam et al, 1971,
1972; Nahmias et al., 1976; Anzai et al., 1975).

Patients with cervical

carcinoma showed positive correlation with antibody levels against
Herpes simplex virus.

In addition, human cervical neoplastic cells have

been reported to contain DNA sequences identical to fragments of the
HSV 2 genome (Frenkel et al., 1972; Roizman and Frenkel, 1973).

In the last decade, animal systems have been developed using
inactivated herpesviruses as cell-transforming agents.

Duff and Rapp

(1973,1974) used UV-inactivated herpesviruses to induce conversion of
normal hamster cells into neoplastic cell lines.

In 1975 Boyd and Orme

reported that partially UV light-inactivated HSV 2 (Savage strain) had
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been used to tranform a BALB/c mouse fibroblastic cell line (238) into a
permanent malignant cell line (H238).

This malignant cell line (H238)

had the ability to induce tumors when inoculated into syngeneic BALB/c
mice (Boyd and Orme, 1975).

Dr. Robert L. Nutter obtained the H238 cell line from
Lewis Boyd, Frederick, MD.

Dr. Ann

These cells have been used for several years

to produce tumors in BALB/c mice in tumor immunology studies along with
other mouse and rat tumor models.

Previous Work Done in our

Laboratories

In the past, investigators in our laboratories have studied the
ability of 14 different diets to restrict or enhance tumor growth.
These diets varied in the level (11% or 33%) and source (milk, soy.
wheat, fish, and beef) of protein and in the level (5% or 30%) of fat
(corn oil) (Gridley et. al., 1982).

This study reported that the diet

found to be most restrictive toward the growth of H238 tumor cells in
BALB/c mice, contained a low level of fat (5%) with casein (11%) as the
protein source (Diet 1).

The diet which promoted most tumor growth

contained a high level of fat (30%) with wheat gluten (11%) as the
protein source (Diet 4).

In view of these results, a follow-up study was conducted using
Diets 1 and 4 only.

In this second study, weanling BALB/c mice were fed
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one diet or the other for 12 weeks before being injected with H238
cells.

The mice were divided into 14 equal groups, seven for each diet.

At weekly intervals, during weeks one through seven after injection.
tumor volumes were measured and one group from each diet was euthanized
and autopsied.

Cells from the spleen and blood were taken; differential

counts were made on these cells, and microcytotoxicity assays were
performed (Nutter et al., 1982).

Further studies were performed using a chemically transformed
tumor cell line (1,2-dimethyl-hydrazine transformed cells - #51) in
BALB/c mice (Nutter et al., 1983a) and spontaneous mouse mammary tumors
(involving the mouse mammary tumor virus) in C3H mice (Gridley et al..
1983) using the original 14 different diets.

These studies indicated a

higher incidence and rate of tumor growth in mice fed Diet 4.

In

contrast, mice fed Diet 1 had a lower tumor incidence and rate of tumor
growth.

In the intervening period of time between the conclusion of the
above-mentioned experiments and the present project, it became popular.
in diet-tumor studies, to view the comparison of the effects of diets
with equal nutrient to calorie ratios of greater importance than a
comparison of the effects of diets with equal number of calories per
gram.

It seemed important, then, in future experiments to employ equal

nutrient to calorie ratios, which means equal protein to calorie ratios.
equal vitamin to calorie ratios for each of the vitamins and equal
mineral to calorie ratios for each of the minerals.

This meant that the
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source of protein, wheat gluten, would have to be carefully analyzed for
each of these constituents and the amounts of the added vitamins and
minerals adjusted accordingly.

It also meant that the amount of Celufil

or Alphacel (non-nutritive fillers) should be adjusted in the
comparative diets.

In previous studies done in our laboratory with equal numbers of
calories per gram, diets with higher percentages of fats had higher
amounts of Celufil since the numbers of calories per gram of fat is
greater than the numbers of calories per gram of protein or carbohydrate
by a ratio of nine to four.

In the new diets, fat calories were added

at the expense of carbohydrate calories.

This adjustment was made on

the basis of the finding that mice and rats tend to eat to satisfy their
own caloric needs.

That is to say that animals fed a high fat diet with

higher calories per gram eat less than equivalent animals fed a low fat
diet, so that the number of calories consumed per day is approximately
the same for the two diets.

Another improvement in experimental design was considered important
enough to be included in future experiments with Diets 1 and 4.

Since

these diets were different in two respects: source of protein, and level
of fat, it seemed advantageous to add two more diets in order to be able
to determine whether differences with the two diets, with respect to
immune response and tumor growth, were primarily due to differences in
the source of protein or to differences in the level of fat.
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The project described in this thesis was designed to incorporate
these four diets, each with equal nutrient to calorie ratios.

GOALS OF THE RESEARCH PROJECT

PART I.

DIET STUDIES

The original plan was to divide a large group of weanling BALB/c
mice into four diet groups with all four diets having equal nutrient to
calorie ratios.

The diets would be of the following nature:

Diet 1 - low protein (11% casein) - low fat (5% corn oil).
Diet 2 - low protein (11% wheat gluten) - low fat (5% corn oil).
Diet 3 - low protein (11% casein) - high fat (30% corn oil).
Diet 4 - low protein (11% wheat gluten) - high fat (30% corn oil).

After 12 weeks all the mice would be injected with H238 cells.
Previous experiments performed in Dr. Nutter’s laboratory indicated that
immunodepression did occur in animals developing H238 cell-induced
tumors.

Since the lymphocyte transformation assay has been shown under

many conditions to be a reliable indicator of immune competence, and has
been routinely used in past dietary studies with convincing results, it
was selected again for use in this study.

In addition, since a unique

relationship has been observed in previous dietary studies, between
spleen function and tumor growth, it was decided to further investigate
the effects of the four diets on tumor development, spleen weights and
overall immune responses.
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For this purpose, at nine different times in the following seven
weeks mice from each of the four diet groups would be weighed and
euthanized, their tumors would be measured, their spleens would be
weighed, the spleen cells would be removed for differential counts, and
would be used for various tests of cell-mediated immunity (CMI).

One aim was to determine if, under conditions of equal nutrient to
calorie ratios, increased tumor growth and lower cell-mediated immunity
(seven weeks after H238 cell injection) would be associated with Diet 4
as compared to Diet 1, and, if so, were the differences largely due to
the higher fat in Diet 4 or to the use of wheat protein rather than milk
protein.

Another aim of the project was to determine if an increase in

CMI would occur at approximately four weeks after H238 cell injection
before decreasing again, especially in mice fed Diet 1.

However, prior to testing the immune responses of the mice, a
dietary error was discovered for Diets 2 and 4.

This made it difficult

to study the mice from all 4 diets simultaneously and the original plan
was revised.

Mice fed diets 1 and 3 were studied first, with mice fed

diets 2 and 4 studied later.

In the course of performing these

experiments considerable variation in the results was encountered from
week to week in the lymphoproliferation assay portion of the experiment.

17
PART II.

TESTS PERFORMED TO EXAMINE POSSIBLE FACTORS FOR THE VARIABLE
RESULTS OF THE LYMPHOPROLIFERATION TEST

After the above described experiments were completed, another set
of experiments was performed with the aim of determining some of the
various factors responsible for the existing variability in the
lymphoproliferation assay and the degree to which they might affect the
assay results.

The individual experiments were designed to test:
1)

The effect of different spleen cell concentrations.

2)

The effect of different lengths of time of exposure of cells
between their removal from the animal and their plating.

3)

The effect of more than one source of serum in the medium.

4)

The effect of the use or non-use of ACK lysing buffer in spleen
cell treatment.

5)

The effect of more than one preparation of the same mitogen.
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PART III.

EXPERIMENTS DESIGNED TO IMPROVE TECHNIQUES TO BE USED IN
FUTURE STUDIES

In addition to the tests related to the lymphoproliferation assay.
two other experiments were performed.

The first was designed to test if

mouse tumor volume determinations were the same or significantly
different when two individuals measured tumor length, width and height
on the same three mouse tumors without knowledge of their identity.

The second experiment was planned to test a method designed to
prevent the variability introduced, when lymphoproliferation assays are
performed at different times,

One way in which to avoid this

variability might be to prepare one preparation of H238 cells and divide
it into several aliquots for freezing in liquid nitrogen and thawing for
use as needed for injection.

This experiment was designed to test for

variability in H238 cell viability in 10 aliquots treated in this
fashion.

MATERIALS AND METHODS

PART I.

DIET STUDIES

In the first part of this project the immune status of mice bearing
H238 cell-induced tumors was studied and changes in immune response with
time and with altered diet of the mice were measured.

In the diet

experiments, mice were fed one of the four selected diets ad libitum,
injected with H238 cells, and sacrificed one to nine weeks postinj ection.

Non-injected mice served as controls.

Tumor volume measurements were performed in all H238 cell-injected
mice once or twice a week.

At sacrifice each mouse and its spleen were

weighed and relative spleen weights (RSW) were calculated.

The spleen

cells were used in a microculture lymhocyte transformation test, using
phytohemagglutinin (PHA), concanavalin A (ConA) and lipopolysaccharide
(LPS) as mitogens.

Spleen cell differential counts (SCDC) were also

performed on most of the diet mice.

Statistical analyses were done on

the results with the use of a computerized Student's

T test to deter

mine significant differences (P values).

Animals

A total of 952 male BALB/c mice were obtained from The Jackson
Laboratory (Bar Harbor, ME).

The animals were five weeks old.

Upon

arrival, they were randomly separated into four groups, marked with
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picric acid (so that each mouse could be followed during the course of
the study), and housed 7 to a cage (a total of 136 cages).

Each group

of mice was fed one of the four selected diets ad libitum and was given
tap water.

The weight gained and the amount of food consumed by each

animal were monitored on a weekly basis.

Due to a typographical error, potassium sulfate (K^SO^) was
As a result, mice on these

inadvertantly omitted from Diets _2 and -4.

two diets did not gain any weight for a period of four weeks.

We were

able to correct this mistake, but unfortunately, we were unable to
conduct all four diets simultaneously.
a time.

We were limited to two diets at

To begin with, we selected Diet _1 and Diet 3^, and at this point

the interest of my research was shifted towards these two diets with an
emphasis on the effect of the level of fat.

Although some of the mice fed Diets 2 and 4 died before the diet
error was found and corrected, many of the mice recovered well and grew
normally.

Those mice which had attained a certain body weight by the

time of injection of H238 cells were selected out and used in the
experiment.

The mean weight of mice fed Diet 2 was 26g; the mean weight

of those fed Diet 4 was 27g.

Diet Composition

In Diets 1 and 3, the source of protein was casein (United States
Biochemical Corporation, Cleveland, OH).

A detailed analysis of each of
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the constituents (vitamins and minerals) contained in casein protein was
provided by the manufacturing company.

Diet 1 (11% protein-casein.

5% fat- corn oil) was prepared based on this analysis and the
recommended amounts of commercially prepared vitamins and minerals were
added (Tables IA, IIA) to make them conform to the levels recommended by
the American Institute of Nutrition (AIN) Diet 76A (Table IIIA).
Calculations and adjustments were made in order to prepare Diet 3
(11% protein casein, 30% fat-corn oil),

Diet 3 was identical to Diet 1,

except that the additional amount of fat (corn oil) was added at the
expense of the carbohydrates (dextrin, sucrose) in this diet.

In this

way. Diet 1 and Diet 3 were kept equal for each nutrient to calorie
ratio (Table I).

In Diets 2 and 4, the source of protein was wheat gluten (vital
wheat gluten, Capitol Milling Co., Los Angeles CA).

According to the

manufacturers, the "Manildra Process" was used in concentrating the
protein portion of the flour.

Samples of wheat gluten were analyzed

(Hazleton Laboratories America, Inc., Madison, WI) and the amounts of
vitamins, minerals, carbohydrates and fat contained in wheat gluten were
reported.

Following analysis, the percentages of each component

(vitamins and minerals) necessary to ensure isocaloric diets (with
respect to an equal nutrient to calorie ratio) were calculated.
Appropriate amounts of vitamins and minerals were added in our
laboratory and corn oil (Best Foods, Inglewood Cliffs, NJ) provided the
source of fat (5% or 30%).

Dextrin (United States Biochemical

Corporation, Cleveland, OH) and sucrose (California and Hawaiian Sugar
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Company, San Francisco, CA) were added to equalize the bulk (Table II).

In order to demonstrate the methods used in calculating the
proportions of each of the ingredients used in making up the diets,
illustrations dealing with Diets 2 and 4 are included in the Appendix A.
Also included in the Appendix A are sample calculations for determining
the amount of one of the minerals and the amount of one of the vitamins
used in preparing the special mineral mix and vitamin mix employed in
the diets containing wheat gluten as the protein source.

Tumor Cell Line (H238)

A BALB/c mouse embryonic fibroblast cell line (238) was originally
transformed by (UV)-inactivated herpes simplex virus Type 2, Savage
strain.

The cell line was originally obtained from Dr. Ann Lewis Boyd

(Frederick, MD) and stored in ampoules in liquid nitrogen at a
concentration of 1 X 10

cells/ml.

The passage number of the H238 cells

used for injection was between 30 to 35 passages from the time they were
originally transformed.

Cell Culture Medium

H238 cells were grown in Dulbecco’s Modified Eagle's medium (Irvine
Scientific, Santa Ana, CA).

Roswell Park Memorial Institute RPMI-1640

medium was used in any procedure involving lymphocytes.

Both media were

supplemented with 10% fetal calf serum (Irvine Scientific Company, Santa

TABLE I.

COMPOSITION OF DIETS 1 AND 3 AND KCALS PROVIDED BY EACH MAJOR CONSTITUENT.
DIET 3

DIET 1
. a
Reals

(% by weight)
Casein

11 X 4 = 44

12.14
5.0
48.57
24.29
1.0
3.5
0.2
5.0

TOTAL

100

16.28

_ a
Reals
14.75 X 4 = 59

0.4

0.3

DL-Methionine
Corn oil
Dextrin
Sucrose
AIN-76A Vit. (commercial)
AIN-76A Min. (commercial)
Choline Bitartrate
Celufil

DIET 1: 11% protein (casein)

(% by weight)

5 X 9 = 45
0.94X48.57X4=182.6
24.29 X4 = 97.16

368.8

30.00
26.88
13.44
1.34
4.69
0.27
6.7

30.00 X 9 = 270
26.88X0.94X4=101.07
13.44 X 4 = 53.76

100

483.83

5% fat (corn oil)

DIET 3: 14.75% protein (casein), 30% fat (corn oil)
Applicable if % by weight is expressed in grams.

ho
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TABLE II.

COMPOSITION OF DIETS 2 AND 4 AND KCALS PROVIDED BY EACH MAJOR CONSTITUENT.
DIET 2
(% by weight)

Wheat

14.14

DL-Methionine
Corn oil
Dextrin
Sucrose
AIN-76A Vit. (ours)
AIN-76A Min. (ours)
Choline bitartrate
Celufil
Lysine3
Threonine3
TOTAL

0.3
4.50
47.10
23.55
1.0
3.5
0.2
5.0
0.52
0.195
100

DIET 4
Reals b

(% by weight)

11 X 4 = 44
5 X 9 = 45
0.94X47.10X4=177.1
23.55 X 4 = 94.2

360.3

DIET 2:

11% protein(wheat) - 5% fat (corn oil)

DIET 4:

14.75% protein (wheat) - 30% fat (corn oil)

18.96
0.4
29.32
24.90
12.44
1.34
4.70
0.27
6.70
0.70
0.26
100

Reals k
14.75 X 4 = 59
30.00 X 9 = 270
0.94X24.90X4=93.7
12.44 X 4 = 49.8

472.5

3Diet 2 and 4 were supplemented with Lysine and Threonine (essential amino acids) because wheat
protein is deficient in these two essential amino acids.
^Applicable if % by weight is expressed in grams.

N3
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Ana, CA), 10 mg/ml of gentamicin (Valley Biologies, Inc., State College,
PA), and 1.35 mg/ml of fungizone (E. R. Squibb and Sons, Inc.,
Princeton, NJ).

Buffers: Tris Buffered Saline (TBS) pH=7.4,
Ammonium:Chloride:Potassium (ACK) lysing buffer pH=7.4, and Trypsin
pH=7.2 were the buffers used in these experiments.
as follows: A) TBS:

0.14 M NaCL,

5.1 mM KCL,

Their formulas are

0.38 mM Na2HP04.7H20,

0.56 mM Dextrose (anhydrous).

0.025 M Tris- (hydroxymethyl)

aminomethane (Schwartz/Mann),

0.018 M cone HCL,

0.9 mM CaCL2.

B) ACK:

0.01 M KHC03,

0.49 mM MgCL2.6H20 and

0.16 M NH.CL and 0.1 mM Na0EDTA.
4
2

C) TRYPSIN: 10% (W/V).

All media and buffers were prepared in deionized H20 (equivalent to
double distilled H20) and filter sterilized.

Procedure for Freezing H-238 Cells

Cells from several culture bottles were washed once with Trypsin
(2-3 ml per culture bottle, Difco Laboratories, Detroit, MI), harvested
with 1 ml of warm trypsin (per culture bottle), triturated with a
pipette, and pooled into a sterile 50 ml (screw-cap) centrifuge tube.
The tube contained 5 ml of fetal bovine serum (Irvine Scientific, Santa
Ana, CA) in order to stop the action of trypsin.

The temperature of the

centrifuge tube was lowered by placing it in an ice bath until the
temperature was between 3 and 4 °C. The cells were washed twice with
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20-40 ml of TBS.

After the second centrifugation at 175XG for 5

minutes, the supernate was poured off from the centrifuge tube.
Following this, 1-2 ml of chilled (0-4°C) freeze-medium (complete
Dulbecco's modified Eagle’s medium, Irvine Scientific, Santa Ana, CA,
supplemented with 10% fetal calf serum and 10% dimethylsulfoxide, J. T.
Baker Chemical Co., Phillipsburg, NJ) was added.
resuspended in the freeze medium.

The cells were gently

The temperature was kept low by using

the ice bath throughout the procedure.

The number of viable (clear)

cells was counted in a hemocytometer (American Optical Company, Buffalo,
NY) using 0.1 ml of the cell suspension, 0.9 ml of TBS, and 1 drop of
trypan blue.

The suspended cells were then diluted with additional cold

freeze-medium to give the desired cell concentration of 1 X 10
cells per ml.

live

One milliliter aliquots were pipetted into cold, plastic.

screw-cap ampoules (Irvine Scientific, Santa Ana CA).

The ampoules

containing the cells were slowly cooled by successive incubation at 4°C
for two hours (ordinary refrigerator), into a regular freezer (-25°C)
for four hours, then into a low temperature freezer(-90°C) overnight.
The next day, the ampoules were transferred to a liquid nitrogen freezer
for long term storage.

Procedure for Reconstituting Frozen H-238 Cells

During reconstitution, the frozen cells were rapidly thawed in a
37°C waterbath with agitation.

The cell suspensions were diluted with

6 ml complete Dulbecco's MEM medium containing 10% fetal calf serum.
The cells were dispensed into three T-25 plastic tissue culture flasks
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(Falcon Plastics, Oxnard, CA).

The flasks were checked the following

day for an evidence of growth.

The medium was replaced every 48 hours

with fresh growth medium.

A monolayer was formed in 3-4 days.

Subsequently, the cells were split 1:5 and incubated in culture flasks
containing 10-15 ml of medium to promote fast growth.

Processing of Tumor Cells (H238) before Injection

Prior to injecting the mice, frozen H238 cells of the same passage
number were taken from liquid nitrogen and split several times in vitro
in order to achieve a fast exponential growth.

The cells were then

trypsinized, suspended and washed three times in TBS to remove any
After the third wash the cells were

complete Dulbecco’s medium.

resuspended in 5 ml of TBS, counted in a hemocytometer and adjusted in
TBS to a concentration of

1.67 X 106 cells/ml.

The viability of the H238 cells was determined by counting the
cells prior to and after cell injection.
indicator of cell viability.

Trypan blue was used as an

In all cases the viability of the cells

was 90 percent or greater.

Tumor Cell Inj ection

Ten weeks following arrival, 64% of the mice from diet groups 1 and
3 were injected subcutaneously into the outside portion of the right
thigh with 5 X 10^ H238 cells.

(0.3 ml/ mouse), whereas 36% served as
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This number of cells (5 X 10^) had been shown

non-injected controls,

previously to produce tumors in approximately 70% of BALB/c mice under
ordinary laboratory conditions in several dose-response determinations.

Mice fed Diet 2 or Diet 4 were injected twenty weeks from the time
of their arrival.

Again, 64% of the mice served as the experimental

(tumor-injected) group while 36% of the mice were used as controls.

Animals from all four dietary groups were randomly injected.

Tumor Volume Measurements

Tumor sizes, of each tumor-cell injected animal, were measured
weekly with Vernier calipers. The following formula was used to
determine tumor volume:
tumor volume (mm)

3

= L X W X H
2

where L, W and H
respectively.

represent the length, width, and height of the tumor
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Times when Mice were Taken

The mice were taken and the various tests were conducted as
follows:

DIET (1 & 3)

6 days, 14 days, 20 days, 2 6 days, 2 9 days, 33 days, 3 6 days, 41 days.
48 days, following tumor (H238)-cell injection.

DIET (2 & 4)

7 days, 28 days, 49 days, following tumor (H238)-cell injection.

Relative Spleen Weight (RSW)

Each mouse was weighed immediately before it was euthanized and the
spleen was weighed upon removal.
RSW

The RSW was calculated as follows:

Spleen weight of mouse(g) ^ ^4
Mouse weight(g)

Spleen Cell Differential Counts

Single-cell suspensions of spleen cells from each mouse were
centrifuged (185XG for 5 minutes) and the supernate was discarded.

The
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concentrated cells were vortexed to obtain uniform cell distribution.
Single drops, one from each cell suspension, were placed on separate
slides and smeared with the edge of another slide into a very thin
layer.

After air-drying, the slides were stained with Wright’s stain

using a standard procedure.

One to two hundred cells from each sample

mouse spleen were counted under oil immersion and were identified
according to morphology, size, and staining characteristics as
lymphocytes, polymorphonuclear cells, and macrophages.
of these cells were also noted when present.

Immature forms

The differential counts

were performed by the clinical laboratory at the Loma Linda University
Medical Center.

Lymphocyte Transformation Test

Lymphocyte transformation tests were performed on all mice
(non-tumor injected, and tumor-injected) from all four dietary groups in
order to determine their immune status.

Preliminary experiments had

determined optimal test conditions with respect to concentration of
spleen cells (2 X 10

cells/ ml), amount of phytohemagglutinin (PHA)

(1:40), concanavalin A (ConA)

(1:480), and lipopolysaccharide (LPS)

(1:50) as well as the length of cell incubation.

On particular days, H238 cell-injected and non-injected mice were
randomly selected and euthanized (cervical dislocation).
were aseptically removed and weighed.

The spleens

Single-cell suspensions were

prepared by mashing the spleen with wooden sterile applicator sticks.
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The cell

The number of viable cells were counted in a hemocytometer.
concentration was adjusted to 2 X 10

viable cells/ml using 0.2% trypan

blue as an indicator of cell viability.

From each cell suspension.

0.1 ml aliquots were dispensed with an automatic pipetter (Eppendorf,
VWR Scientific, Los Angeles CA) into the wells of Microtest III culture
plates (Falcon Plastics, Oxnard, CA).

Following this, 0.1 ml of a 1:40 dilution (1 microgram/ 0.1ml) of
commercial PHA-P (Wellcome Research Laboratories, Beckenham, England),
0.1 ml of a 1:480 dilution (0.21 micrograms/0.1ml) of Concanavalin A
(ConA)

(Sigma Chemical Company, St. Louis, MO) or 0.1ml of a 1:50

dilution (10 micrograms/ 0.1ml) of Lipopolysaccharide LPS (Calbiochem,
Behring Diagnostics, La Jolla, CA) were added to triplicate wells.
Control wells received 0.1 ml of medium (RPMI-1640) instead of mitogen.
and 0.1 ml of cells.

They were also done in triplicate.

The plates were incubated for 43 hours in 5% CO^ at 37°C.

At the

end of incubation, cultures were pulse-labelled with 1 microcurie/well
of tritiated thymidine (ICN Radiochemicals, Irvine, CA).
were incubated for an additional five hours.

The plates

The cells from each

microculture plate were then harvested with an M-24S Cell Harvester
(Brandel, Gaithersburg, MD) onto strips of fiberglass scintillation
paper (Whatman, Maidstone, England), and washed several times with a
0.85% saline solution.

The glass fiber discs containing cells were

removed and transferred to glass vials containing 2 ml scintillation
fluid (CytoScint, WestChem, San Diego, CA).

The amount of

3

H-thymidine
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incorporated into the DNA of the cell was counted using an LS 3801
liquid scintillation counter (Beckman Instruments, Irvine, CA) for a
total of 2 minutes.

Data were expressed as mean counts per minute for each mouse,
results for the experimental animals were compared with those of the
controls in each dietary group,

In addition, the data from dietary

group 1 were compared with those of dietary group 3, and the data of
group 2 with group 4.

The
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PART II. TESTS PERFORMED TO EXAMINE POSSIBLE FACTORS FOR THE VARIABLE
RESULTS OF THE LYMPHOPROLITERATION TEST

Due to the high variability that was encountered in the
lymphoproliferative response of control and tumor-injected mice, (on
Diets 1 & 3), it was decided to check possible factors which may affect
test results.

The factors examined were:

A) Variation in spleen cell counts

Spleens were aseptically removed from two non-tumor injected BALB/c
mice (10 weeks of age).

The spleens were mashed with sterile applicator

sticks, and the spleen cell concentration was adjusted to 2.4 X 10
cells/ml, 2.0 X 10
1&3,

f)

cells/ml (optimal cell concentration used for Diets

and 2&4) and 1.6 X 10^ cells/ml in RPMI-1640 medium containing 10%

fetal calf serum (Irvine Scientific, lot number: 504415).

This is the

standard serum lot number contained in the RPMI-1640 medium, used for
the lymphoproliferation assay for mouse spleen cells (Diets 1,3 & 2,4).
Trypan blue (0.2 percent solution) was used as an indicator of cell
viability.

From each cell suspension, 0.1 ml aliquots were dispensed into
wells of two flat bottom Microtest III plates.

Next,

0.1 ml of a 1:50

dilution of PHA-P (Wellcome Research Laboratories, lot number K122410)
were added to half of the ninety six wells of the first Microtest plate.
The rest of the wells received 0.1 ml of RPMI-1640 and served as control
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wells.

The second Microtest plate received 0.1 ml of a 1:60 dilution of

PHA-P (Wellcome, lot number K7185), and 0.1 ml of RPMI-1640 was added to
half of the wells (control wells).

A lymphoproliferation assay was then performed using identical
conditions to those described above.

The data were reported as mean

counts per minute for each spleen cell concentration,

The results of

each spleen cell concentration were compared with those of the other two
cell concentrations.

B) Variation in the length of time of mouse spleen cell
exposure at room temperature

In a separate Microtest III plate, 0.1 ml of mouse spleen cells
(2.0 X 106 cells/ml) were dispensed along with 0.1 ml of PHA-P,
immediately after the cell concentration was prepared.

The remaining of

the cells were kept in a 50 ml capped centrifuge tube and were kept at
room temperature for 2 hours.

After 2 hrs at room temperature.

0.1 ml

of cells were dispensed in two rows of the same Microtest III plate and
0.1 ml of PHA-P was added, while the remaining spleen cells were kept at
room temperature for an additional 2 hours (total 4 hrs).

At the end of

4 hrs 0.1 ml of the remaining spleen cells were plated to two rows of
the same microtest plate.

Each time the spleen cells were plated.

0.1 ml of 1:50 PHA-P was added to half of the wells in each row, while
the rest received 0.1 ml of RPMI-1640 and served as control wells.
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A lymphoproliferation assay was performed using identical
The data were reported as

conditions to those previously described.

mean counts per minute, for each of the time intervals, of spleen cell
exposure at room temperature.

The differences in the results were

compared and analyzed.

C) Variation in the source of fetal calf serum in the medium

Spleen cell concentrations of 2.0 X 10

cells/ml were prepared

using RPMI-1640 medium containing 10% fetal calf serum from three
different sources.

The serum sources and lot numbers used were:

Irvine

Scientific, lot number 504415 (the standard serum in RPMI-1640 medium
used for the lymphoproliferation assay for mouse spleen cells, diets
Irvine Scientific, lot number 409717, and Biolabs, Lot number

1-4);
10610.

Aliquots of 0.1 ml of spleen cells prepared in RPMI-1640 medium
containing serum from the different sources were dispensed with an
automatic pipetter into the wells of a flat bottom Microtest III plate.
Half of the wells in each row received

0.1 ml of PHA-P while the rest

received 0.1 ml of RPMI-1640 which served as control wells.

A lymphoproliferation assay was performed using identical
conditions to those previously described.

The data were reported as

mean counts per minute for each of the above three different serum
sources and the differences in the results were noted.
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D) Treatment of spleen cells with ACK lysing buffer

In a lymphoproliferation assay, a standard alternative method for
the treatment of mouse spleen cells is to remove the erythrocytes using
ammonium chloride potassium (ACK) lysing buffer.

Spleens were aseptically removed from two 10 week old non-tumor
injected BALB/c mice.

Single-cell suspensions were prepared by mashing

the spleen with sterile applicator sticks.

The spleen cells were then

washed in 2 ml of RPMI-1640 medium and centrifuged at 185XG for
5 minutes.

After the cells were centrifuged, 3 ml of ACK lysing buffer

was added to the cells in the test tube.
for 4 minutes at 4°C.

The cells were refrigerated

Following refrigeration 2 ml of RPMI-1640 was

added and the cells were centrifuged at 185XG for 5 min.

The cells were

washed once more and the cell concentration was adjusted to 2.4 X 10 ,
£

2.0 X 106, 1.6 X 10° viable cells per ml using 0.2% trypan blue as an
indicator of cell viability.

The various spleen cell concentrations were prepared using
RPMI-1640 medium supplemented with 10% fetal calf serum of the same lot
number (Irvine Scientific, lot number 504415).

In addition. spleen cells (2.0 X 10 /ml) were prepared using
RPMI-1640 medium containing 10% fetal calf serum from two other sources
(Irvine Scientific, lot number 409717; Biolabs, lot number 10610).
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In summary, possible variables associated with the three factors
listed above were checked and their effect on the lymphoproliferation
assay was determined.
described were used.

Identical test conditions to those previously
Mean counts per minute were obtained for all

samples. The results were compared with those of the spleen cells that
did not receive ACK-lysing buffer treatment.
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PART III.

EXPERIMENTS DESIGNED TO IMPROVE TECHNIQUES TO BE USED IN
FUTURE STUDIES

Since two different individuals were responsible for measuring the
tumor dimensions in mice fed Diets 1 and 3 ( one measured tumors in one
group and the other measured those in the other group), the question was
raised as to whether significant differences in the calculated volumes
were real or were the result of two different people doing the
measuring.

The following experiment was designed to determine how

closely the same two individuals would measure the dimensions of the
same set of tumors.

Tumor volume measurement

In order to determine possible variability in tumor volume
calculations the following exercise was performed.

Tumors from three

tumor-bearing male BALB/c mice were randomly measured ten times by two
separate individuals.

All three animals had relatively large tumors.

To avoid biased recording, the mice were redistributed after each tumor
measurement.

Furthermore, the identity of the animals was concealed in

order to achieve objective assesments.

The measurements were reported by each participant in terms of
length (L), width (W), and height (H).

A third person calculated tumor

volumes using the formula:
n
. 3n
Length(mm) X Width(mm) X Height(mm).
Tumor volume (mm ) = --------------------------------------------------------------2
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The data were subjected to statistical analysis using the Student s
2-tailed t-test and analysis of variance.
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Variability in cell viability and plating efficiency among ten aliquots
from a suspension of H238 cells after freezing at liquid nitrogen
temperature

Ten ampoules (Irvine Scientific, Santa Ana, CA), each containing
equal aliquots of 1 X 10

H238 viable cells were frozen at liquid

nitrogen temperature using the standard freezing procedure previously
described.

Cell viability was determined by counting the number of

cells in a hemocytometer (American Optical Co., Buffalo, NY) using 0.1
ml of the H238 cell suspension, 0.9 ml of TBS, and 1 drop of 0.2 percent
trypan blue.

After 7 days, all the 10 ampoules containing the equal aliquots of
frozen H238 cells (1 X 10

cells) were removed from the liquid nitrogen

storage and rapidly thawed in a 37°C waterbath.

The cells from each

ampoule were reconstituted and recounted using 1 drop of trypan blue as
an indicator of cell viability.

The number of viable (unstained) and

dead (stained) H238 cells, recovered from each ampoule was recorded.

The cells from all 10 ampoules were then diluted to different
concentrations, and plated in soft agar plates (Flat Bottom cell wells.
Corning, NY).

The cell concentrations prepared and plated (in tripli-

cate wells) were: 1 X 104 cells, 1 X 103 cells, 1 X io2 cells, and
50 cells.

The plates were observed every other day for presence of H238 cell
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colonies.

Colonies were counted and recorded (mean of 3 wells of

100 cells) fourteen days after the H238 cells were plated.

Statistical Analysis

Statistical analysis was performed on the data obtained from the
various tests and measurements.

The probability of significance, means.

and standard errors were determined with the use of a computerized
(Hewlett Packard, model 86) Student’s 2-tailed T-test.

The statistical hypothesis tested was whether changes in dietary
fat level (5%-30%) had no effect on tumor growth and the immune
responses of mice.

Comparisons were made between Diet 1 (11% casein-

5% fat) and Diet 3 (11% casein-30% fat) and between Diet 2 (11% wheat
gluten-5% fat) and Diet 4 (11% wheat gluten-30% fat) respectively,

The

alternative hypothesis tested was that changes in dietary fat level
affected tumor growth and immune responses.

A P value of (p 0.05)

indicated that the two measurements compared were significantly differ
ent and the alternative hypothesis was accepted.

RESULTS

PART I.

DIET STUDIES

Tumor incidence and volume

Four groups of mice were fed four different diets, each with equal
nutrient to calorie ratios for protein and for each vitamin and mineral.

Two of the four groups of mice (approximately 227/group) were fed
Diets 1 and 3 respectively, for 10 weeks, prior to H238- cell injection.
Mice from the other two diet groups were fed Diets 2 and 4 respectively.
for 20 weeks.

The number of animals in these two groups was smaller

(84/group) with the loss of animals due to an error in diet composition.
A direct comparison between Diets 1,2,3 and 4 was not possible since all
four diet-tumor systems were not tested simultaneously.

A comparison

could be performed between Diets 1 and 3, and between Diets 2 and 4
respectively.

Tumor volume measurements were performed once a week (weeks
2,3,6,7) or twice a week (weeks 4 and 5) for mice fed Diets 1 and 3.
Injected mice from both Diet groups (1 & 3) had a high incidence of
tumors, 92.1% and 90.0% respectively.

The proportion of mice in which

tumors regressed completely by seven weeks after injection, was found to
be approximately the same in the mice fed Diets 1 and 3, 2.15% and 2.08%
respectively.
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No tumors were found in the non tumor cell-injected mice throughout
the study.

Tumors began to appear in both groups (Diets 1 & 3) at

approximately 1 week after the injection of the H238 tumor cells
(Table III, Fig. 1) .

The mean tumor volume for the mice fed Diet 1 was

significantly lower (P\<0.05) than that for those fed Diet 3 at
3-5.5 weeks after tumor cell injection.

In both groups, however, once

the tumors began to develop, a weekly increase in mean tumor volume was
observed.

Tumor volume measurements were performed once a week (weeks 2,3,7)
and twice a week (weeks 4,5,6) for mice fed Diets 2 and 4 (Table IV,
Injected mice from both Diet groups 2 and 4 had 100% incidence

Fig. 2).
of tumors.

Furthermore, no tumor regression was noted in mice from

either the Diet 2 or 4 groups.

No tumors were found in the non tumor

cell-injected mice throughout the study.

Tumors began to appear in both

groups at approximately 1 week after the injection of the H238 tumor
cells.

The mean tumor volume for the Diet 2 mice was significantly

lower (P'50.05) than that for those fed Diet 4 over the entire range from
2 weeks through 7 weeks after tumor cell injection.

In both groups.

however, once the tumors began to develop, a weekly increase in mean
tumor volume was observed.

In an attempt to speculate what might have occurred between Diets
1,2,3,4, had it been possible to compare them directly, mean tumor
volume measurements from all four dietary groups were plotted together
(Fig. 3).

Mice fed Diet 4 had the greatest tumor volumes while mice fed

TABLE HI.

THE RELATIONSHIP OF TUMOR VOLUME TO TIME AFTER INJECTION OF H238 CELLS
DIET 3

DIET 1
Weeks of Measurement
2a
3
4
4.5
5
5.5
6
7

Mean

+

+
123.4 l
+
242.5 +
477.7 l
+
669.2

Std. Error
8.6

b, c

Std.
Deviation
101.7

12.9

142.1

30.8

318.7

44.9

423.9

+
951.8 - 73.4

622.4

+
1268.9 - 107.2
+
1945.6 l 207.3
+
2630.0 - 388.8

787.7
1226.4
1603.0

N

Mean

+

+
111.6 +
122 353.2
+
107 575.8
+
89
891.8
+
72 1285.8 +
54 1535.3
+
35 2046.4 +
17 2335.0 139

Std. Error

Std.
Deviation

P
N

Value
0.20

10.5

96.7

85

22.5

256.1

129

0.0001

33.3

347.7

109

0.02

55.4

528.4

91

0.001

92.7

786.9

72

0.003

120.3

932.0

60

0.05

189.0

1149.5

37

0.36

295.7

1254.6

18

0.27

^ice fed Diets 1 and 3^ had no detectable tumors at 1 week post-injection of H238 cells.
b

Mean tumor size at greatest tumor diameter and standard error expressed in millimeters.

Thigh size for uninjected control mice was 6mm.
Note: The mean tumor size is presented only for those mice which had a detectable tumor at each
weekly time interval. Also, only those mice in which tumors did not regress during the
entire 7-week post- H238 cell injection period are included.
c

The formula used to determine tumor volumes was:

Tumor volume (mm)

3

=

L X W X H
2
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FIGURE 1. MEAN TUMOR VOLUMES AND STANDARD ERRORS OBTAINED AT
VARIOUS TIME INTERVALS FROM ALL TUMOR CELL-INJECTED MICE.
DIET 1 INDICATES AN 11% CASEIN DIET, LOW IN UNSATURATED FAT WHILE
DIET 3 INDICATES AN 11% CASEIN DIET, HIGH IN UNSATURATED FAT.
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FIGURE 1. TUMOR VOLUME VERSUS TIME (WEEKS) AFTER TUMOR CELL INJECTION.
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TABLE IV.

THE RELATIONSHIP OF TUMOR VOLUME TO TIME AFTER INJECTION OF H238 CELLS

DIET 2

+ Std. Error
Mean

Weeks of Measurement

+

3

393.4 l 31.4
+
37.6
613.3

4

+ 36.9
887.2

2a

4.5
5
5.5

b ,c

+

37.2
+
1747.8 l 54.7
+
2126.6 - 66.8
1267.2

Std.
Deviation
185.6
222.7
218.2

DIET 4
N

Mean

35

715.7

+ 32.5
+

Std.
Deviation

N

P
Value

189.6

34

0.0001

1024.4

36.2

210.8

34

0.0001

35

+
1709.2
54.7

317.6

34

0.0001

488.7

17

0.0001

564.8

17

0.0001

870.5

17

0.0001

1029.0

17

0.0001

913.4

17

0.0001

1067.2

17

0.0001

153.5

17

225.5

17

275.4

17

473.8

17

6.5

3751.1

695.6

17

7

+
4084.0 1 198.2

817.2

17

aMice fed Diets 2 and 4

Std. Error

35

+ 114.9
3089.5
+ 168.7

6

+

+

118.5
+
3006.1 - 137.0
+
211.1
3807.0
+
5230.9 - 249.6
-f
6186.9
221.5
+
7423.5 - 258.8
2330.3

had no detectable tumors at 1 week post-injection of H238 cells.

^Mean tumor size at greatest tumor diameter and standard error expressed in millimeters.
Thigh size for uninjected control mice was 6mm.
Note: The mean tumor size is presented only for those mice which had a detectable tumor at each
weekly time interval. Also, only those mice in which tumors did not regress during the
entire 7-week post- H238 cell injection period are included.
c
. N3
The formula used to determine tumor volumes was: Tumor volume (mm) = L X W X H
2
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FIGURE 2. MEAN TUMOR VOLUMES AND STANDARD ERRORS OBTAINED AT
VARIOUS TIME INTERVALS FROM ALL TUMOR CELL-INJECTED MICE.
DIET 2 INDICATED AN 11% WHEAT GLUTEN DIET, LOW IN UNSATURATED
FAT WHILE DIET 4 INDICATES AN 11% WHEAT GLUTEN DIET, HIGH IN
UNSATURATED FAT.
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FIGURE 2.

TTJMOR VOLUME VERSUS TIME (WEEKS) AFTER TUMOR CELL INJECTION.
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Diet 1 had the least tumor volumes.

Relative spleen weight (RSW)

Relative spleen weights were determined for each mouse at the time
of euthanization.

All of the mice in Diet groups 1 and 3 that exhibited

growing tumors developed splenomegaly by 3-4 weeks after H238 cell
injection (Fig. 4).

Significantly lower (P^0.05) values were obtained

for the group fed Diet 1 than for those fed Diet 3, 5 to 7 weeks after
H238 cell injection.

No significant differences in RSWs were observed when mice fed
Diet 2 were compared with mice fed Diet 4 (Fig. 5).

However, there were

trends with RSW values for mice fed Diet 2 being greater than those for
mice fed Diet 4 at 4.5 and 7 weeks after H238 cell injection.

Spleen Cell Differential Counts

Spleen cell differential counts (SCDC) were performed on all diet
mice groups at the time of euthanization.

One to two hundred cells from

each sample mouse spleen, (tumor-injected and non-tumor injected mice)
were counted and identified according to morphology, size, and staining
characteristics.

The greater percentage of mature lymphocytes present in the spleens
of mice fed Diet 1 were statistically significant (R£0.05) compared to

51

FIGURE 3. MEAN TUMOR VOLUMES OBTAINED AT DIFFERENT DAYS FROM
ALL TUMOR CELL-INJECTED MICE. DIET 1 AND 3 INDICATES AN 11%
CASEIN DIET LOW OR HIGH IN UNSATURATED FAT RESPECTIVELY, WHILE
DIET 2 AND 4 INDICATES AN 11% WHEAT GLUTEN DIET LOW OR HIGH IN
UNSATURATED FAT RESPECTIVELY.
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FIGURE 4. MEAN RELATIVE SPLEEN WEIGHTS AND STANDARD ERRORS
OBTAINED AT VARIOUS TIME INTERVALS FROM ALL TUMOR CELL-INJECTED
MICE FED DIET 1 (11% CASEIN- 5% CORN OIL) OR DIET 3 (11% CASEIN30% CORN OIL).
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FIGURE 4.

RELATIVE SPLEEN WEIGHTS OF MICE AT WEEKLY INTERVALS AFTER H238 CELL INJECTION.
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FIGURE 5. MEAN RELATIVE SPLEEN WEIGHTS AND STANDARD ERRORS
OBTAINED AT VARIOUS TIME INTERVALS FROM ALL TUMOR CELL-INJECTED
MICE FED DIET 2 (11% WHEAT GLUTEN- 5% CORN OIL) OR DIET 4
(11% WHEAT GLUTEN- 30% CORN OIL).
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FIGURE 5.

RELATIVE SPLEEN WEIGHTS OF MICE AT WEEKLY INTERVALS AFTER H238 CELL INJECTION.
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mice fed Diet 3 at 33 and 48 days after H238 cell injection (Table V).
In addition, the values were higher but not statistically significant (P>
In

0.05) at days 36 and 41 respectively, following H238 cell injection.
mice fed Diets 2 and 4 the results were opposite of those fed Diets 1
and 3.

The percentage of mature lymphocytes were significantly greater

(P^0.05) for mice in Diet group 4 than for those in Diet group 2 at 28
and 49 days, following H238 cell injection (Table VI).

Lymphoproliferative Response of spleen cells to PHA, ConA and IPS
stimulation.

Spleen cells from mice, from all four dietary groups, were treated
with three different mitogens (PHA, ConA, LPS) and were subjected to a
lymphoproliferation assay at different time intervals.

The results were

recorded as counts per minute (cpm), and were plotted against the time
(days) that the cells were obtained following tumor-cell injection.

In

addition, cpm values obtained from dietary groups 1 and 2 were compared
with those obtained from dietary groups 3 and 4 respectively.

The patterns for these values, when plotted, show evidence for
variation with time.

Specifically, the values for mice fed Diet 1

increased when those values for mice fed Diet 3 increased, and decreased
when they decreased, respectively.

Also, the general pattern of the

plot for cells treated with ConA is very similar to that for cells
treated with PHA (Fig. 6, 7, 8).

These observations make it unlikely

that one can have any confidence in the individual values when comparing

MEAN SPLEEN CELL DIFFERENTIAL COUNTS3

TABLE V.

Mature lymphocytes ( Tumor-injected mice)
P
Days

No. of Mice

Diet 1

No. of Mice

Diet3

Value

+
95.4 - 1.2

0.0435

6

9

+
97.6 - 0.4

8

14

12

93.6 - 2.0

14

14

+
93.6 1 1.7

13

26

15

29

16

+
87.7 - 2.8
+
94.1 - 1.6

33

17

36

18

41

17

48

15

20

89.4 +
88.2 +
76.4 +
88.2 -

1.6

13

96.4 t
+
95.9 +
88.9 +
95.0
+
79.3 -

6.5

0.0498

1.7

17

84.5 - 2.0

0.0882

3.8

16

0.3270

3.3

14

73.8 - 4.4
+
84.7 - 1.0

15
18

1.4

0.1257

1.2

0.1524

2.0

0.3728

0.8

0.2920

0.0504

aSpleen cell differential counts (S.C.D.C.s) are based on a count of 100-200 cells/spleen.
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TABLE VI.

MEAN SPLEEN CELL DIFFERENTIAL COUNTS3
Mature lymphocytes (Tumor-injected mice)
P

Days

No. of Mice

7

18

95.4 +- 4.15

18

94.72 +1 5.01

0.30

28

18

+
92.22 - 0.80

18

+
94.33 - 0.84

0.03

49

16

+
77.01 - 2.45

15

+
83.66 - 3.10

0.05

Diet 2

No. of Mice

Diet 4

Value

£1

Spleen cell differential counts (S.C.D.C.s) are based on a count of 100-200 cells/spleen.
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cpm values from one sample time with another,

An attempt was made to

adjust for this variation by subtracting the comparable cpm values from
non-injected mice from those of H238 cell-injected mice.
with Diets 1 and 3, the cpm values

Unfortunately,

for the spleen cells treated with

PHA or ConA (Fig. IB, 2B) from non-injected mice did not follow a
pattern similar to that for those from the injected mice, but were quite
irregular.

This may have been due, partially at least, to the small

numbers of non-injected mice used.

The attempt, then, to normalize the

cpm values for cells treated with PHA or ConA from mice fed Diets 1
and 3 produced results which were less satisfactory than when the
uncorrected cpm values for the tumor-bearing mice, alone, were used.
Although, as mentioned previously, there was evidence of unequal
conditions (making comparisons from one week to the next unreliable).
there were noticeable differences between values for the different diets
on the same day, especially in the later stages of tumor development
(Table VII, Fig. 6,7,8).

However, when LPS was used as mitogen with spleen cells from mice
fed Diets 1 and 3 (Fig. 3B), the normalization by subtraction was
helpful in stabilizing the week-by-week variation without destroying the
observed differences in cpm values with diet.

In the case of the lymphoproliferation assay for Diets 2 and 4,
there were only three sampling times (instead of 9 for diets 1 and 3).
The patterns for all three mitogens used (PHA, ConA and LPS) were such
that differences between the results for Diet 2 and Diet 4 could be

TABLE VII.

RESULTS FROM THE LYMPH OP ROLIFE RATION ASSAYS ON CELLS FROM H238-TUMOR CELL INJEC
TED MICE FED DIETS 1 AND 3a
DIET 1

Mitogens

20 days

36 days

10,984.00- 2,258d

+
36,672.00- 5,721

PHA
Con A
LPS

41 days
+
b
110,473.20- 11,198

49 days
+
49,106- 5,454

119,692.11- 64,581C

51,011- 6,212
86,693- 7,854

DIET 3
PHA
ConA
LPS

+
16,998.00- 2,437

+
65,108.40- 7,671

+
47,788- 5, 122

90,640.50- 11,033

76,596- 8,554

+
4,473.00- 633

6,422- 1,678

P values
LPS: 0.04e

LPS: 0.0001

PHA: 0.001
ConA: 0.05

PHA: 0.016
ConA: 0.02
LPS: 0.0001

aPoints on the lymphoproliferation assay curves for spleen cells from tumor-bearing mice fed
Diet 1 and 3 are included.
b ,c ,d

Values are mean counts per minute and standard errors obtained from wells containing PHA or

ConA or LPS respectively as mitogen.
0

Counts per minute values from tumor-bearing mice were subjected to statistical analysis(student's-2-tailed t-Test), and the resulting P values indicated significant differences(p_0.05)
between Diets 1 and 3.
h-1
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FIGURE 6. LYMPHOPROLIFERATIVE RESPONSE OF SPLEEN CELLS AFTER
STIMULATION WITH PHA. THE PROLIFERATIVE RESPONSE OF CELLS FROM
MICE WAS MEASURED AT VARIOUS TIME INTERVALS AFTER INJECTION OF
H238- TUMOR CELLS. UPTAKE OF 3H- THYMIDINE WAS THE INDICATOR
OF CELL PROLIFERATION. THE MEAN COUNTS PER MINUTE OBTAINED FROM
TUMOR- BEARING MICE FED DIET 1 (11% CASEIN- 5% CORN OIL) ARE
SHOWN RELATIVE TO THE MEAN COUNTS PER MINUTE OBTAINED FROM TUMOR
BEARING MICE FED DIET 3 (11% CASEIN- 30% CORN OIL).
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FIGURE 6.

RESPONSE OF SPLEEN CELLS TO PHA STIMULATION AT VARIOUS TIME INTERVALS AFTER H238 CELL INJECTION.
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FIGURE 7. LYMPHOPROLIFERATIVE RESPONSE OF SPLEEN CELLS AFTER
STIMULATION WITH CONA. THE PROLIFERATIVE RESPONSE OF CELLS FROM
MICE WAS MEASURED AT VARIOUS TIME INTERVALS AFTER INJECTION OF
H238- TUMOR CELLS. UPTAKE OF 3h- THYMIDINE WAS THE INDICATOR
OF CELL PROLIFERATION. THE MEAN COUNTS PER MINUTE OBTAINED FROM
TUMOR- BEARING MICE FED DIET 1 (11% CASEIN- 5% CORN OIL) ARE
SHOWN RELATIVE TO THE MEAN COUNTS PER MINUTE OBTAINED FROM TUMOR
BEARING MICE FED DIET 3 (11% CASEIN- 30% CORN OIL).
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FIGURE 7.

RESPONSE OF SPLEEN CELLS TO ConA STIMULATION AT VARIOUS TIME INTERVALS AFTER H238 CELL INJECTION.
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FIGURE 8. LYMPHOPROLIFERATIVE RESPONSE OF SPLEEN CELLS AFTER
STIMULATION WITH LPS. THE PROLIFERATIVE RESPONSE OF CELLS FROM
MICE WAS MEASURED AT VARIOUS TIME INTERVALS AFTER INJECTION OF
H238- TUMOR CELLS. UPTAKE OF 3H- THYMIDINE WAS THE INDICATOR OF
CELL PROLIFERATION. THE MEAN COUNTS PER MINUTE OBTAINED FROM
TUMOR- BEARING MICE FED DIET 1 (11% CASEIN- 5% CORN OIL) ARE
SHOWN RELATIVE TO THE MEAN COUNTS PER MINUTE OBTAINED FROM TUMOR
BEARING MICE FED DIET 3 (11% CASEIN- 30% CORN OIL).
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FIGURE 8.
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normalized by subtracting the cpm values for non-injected mice from
those for H238 cell-injected mice.

Following this correction, the cpm

values from mice fed Diets 2 and 4 showed an increase at 28 days
post-injection and then decreased to negative values at 49 days
(Table VIII, Fig. 9, 10, 11).

Similar patterns were observed when mouse

spleen cells were treated with any of the three mitogens (PHA, ConA,
IPS), although ConA treatment gave the highest cpm, and IPS treatment
resulted in the lowest.

Furthermore, spleen cells from mice fed Diet 2

showed a higher response to mitogenic stimulation than spleen cells from
mice fed Diet 4 with significant differences noted, particularly at 7
and 28 days.

TABLE VIII.

RESULTS FROM THE LYMPH OP ROLIFERATION ASSAYS ON CELLS FROM H238- TUMOR CELL
INJECTED MICE FED DIETS 2 AND 4a
7 days
DIET 2

P
DIET 4

VALUE

PHA

194,265.20 - 19,302b

+
154,953.00 - 7,194.12

0.05d

ConA

197,670.00 - 20,687°

+
144,051.00 - 8,812.40

0.05

LPS

Points on the lymphoproliferation assay curves for spleen cells from tumor-bearing mice fed
Diets 2 and 4.
b, c

Values are mean counts per minute and standard errors obtained from wells containing PHA

or ConA respectively as mitogen.
^Counts per minute values from tumor bearing mice were subjected to statistical analysis
(student’s-2-tailed t-Test), and the resulting P values indicated significant differences (p 0.05)
between Diets 2 and 4.
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FIGURE 9. LYMPHOPROLIFERATIVE RESPONSE OF SPLEEN CELLS AFTER
STIMULATION WITH PHA. THE PROLIFERATIVE RESPONSE OF CELLS FROM
MICE WAS MEASURED AT VARIOUS TIME INTERVALS AFTER INJECTION OF
H238 CELLS. UPTAKE OF 3h- THYMIDINE WAS THE INDICATOR OF CELL
PROLIFERATION. THE NET COUNTS PER MINUTE (TUMOR- BEARING MICE
COUNTS PER MINUTE MINUS NON- TUMOR BEARING MICE COUNTS PER MINUTE)
OBTAINED FOR EACH OF THE DIET GROUPS (2 OR 4) ARE SHOW.
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FIGURE 10. LYMPHOPROLIFERATIVE RESPONSE OF SPLEEN CELLS AFTER
STIMULATION WITH CONA. THE PROLIFERATIVE RESPONSE OF CELLS FROM
MICE WAS MEASURED AT VARIOUS TIME INTERVALS AFTER INJECTION OF
H238 CELLS. UPTAKE OF 3H- THYMIDINE WAS THE INDICATOR OF CELL
PROLIFERATION. THE NET COUNTS PER MINUTE (TUMOR- BEARING MICE
COUNTS PER MINUTE MINUS NON- TUMOR BEARING MICE COUNTS PER MINUTE)
OBTAINED FOR EACH OF THE DIET GROUPS (2 OR 4) ARE SHOWN.
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RESPONSE OF SPLEEN CELLS TO ConA STIMULATION AT VARIOUS TIME INTERVALS AFTER H238 CELL INJECTION.
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FIGURE 11. LYMPHOPROLIFERATIVE RESPONSE OF SPLEEN CELLS AFTER.
STIMULATION WITH LPS. THE PROLIFERATIVE RESPONSE OF CELLS FROM
MICE WAS MEASURED AT VARIOUS TIME INTERVALS AFTER INJECTION OF
H238 CELLS. UPTAKE OF 3K- THYMIDINE WAS THE INDICATOR OF CELL
PROLIFERATION. THE NET COUNTS PER MINUTE (TUMOR- BEARING MICE
COUNTS PER MINUTE MINUS NON- TUMOR BEARING MICE COUNTS PER MINUTE)
OBTAINED FOR EACH OF THE DIET GROUPS (2 OR 4) ARE SHOWN.
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PART II.

TESTS PERFORMED TO EXAMINE POSSIBLE REASONS FOR THE VARIABLE
RESULTS OF THE LYMPHOPROLIFERATION TEST

One might speculate that there are many possible factors
responsible for the variable results encountered in the lymphoproliferation assay.

In an attempt to determine the relative importance

of some of these factors several different experiments were performed.
The second part of the project was involved in carrying out these
experiments and analyzing the results.

The Effect of Differences in Cell Concentration on Lymphoproliferation
Assay Results.

A lymphocyte transformation test was performed using mouse spleen
cells at three different concentrations (2.4 X 10
cells/ml and 1.6 X 10^ cells/ml).

6

cells/ml, 2.0 X 10

6

Spleen cells were either subjected to

ACK buffer treatment or they were left untreated,

From each cell

suspension 0.1 ml aliquots were plated and 0.1 ml of mitogen (PHA), from
one of two different lots, (titrated either 1:50 or 1:60) was applied
immediately to half of the cells in the plate wells.

The rest of the

cells received RPMI-1640 medium and served as control wells.

Results

were recorded as mean counts per minute and SI values for each spleen
cell concentration that was either subjected or not subjected to
ACK-buffer lysis, and treated with one or the other lot of PHA.
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The greater spleen cell concentrations gave higher mean counts per
minute (Table IX ) compared to lower spleen cell concentrations for both
the ACK treated and the non-ACK treated group of cells.
were more dramatic when the concentration of 2.0 X 10
compared with that of 1.6 X 10

cells/ml.

The results
cells/ml was

A 20% difference between two

concentrations of spleen cells resulted in approximately a two-fold
difference in mean counts per minute, when PHA source A was used.

This

was true for either non-ACK buffer as well as ACK buffer treated cells.

Furthermore, spleen cells (from all three cell concentrations)
that were subjected to ACK-buffer gave higher counts per minute compared
to those that were not subjected to ACK buffer lysis.

No significant

differences were noted among the three spleen cell concentrations when
the Stimulation Index (SI) values were calculated.

TABLE IX.
A.

THE EFFECT OF DIFFERENCES IN CELL CONCENTRATION ON LYMPH OP ROLIFERATION ASSAY RESULTS

NON- ACK SPLEEN CELL TREATMENTb
Spleen cell concentration
2.4 X 106

Spleen
cell

PHA source A (1:50)

369,274.00 - 10,375C
12,706.00 - 545.0 d

Control

cl

2.0 X 106
+
263,546.0 - 13,743.5
12,340.0 - 651.0

1,6 X 106
+
180,292.0 1 11,640
8,940.5 - 561.0

cpm
28.06

sie
PHA source B (1:60)
Control

19.16

362,590.00 - 24,155C

261,722.00 - 9,894

151,410.0 - 7,550

13,052.00 - l,005d

12,209.00 - 551.0

8,715.0 - 452.0

26.77
B.

20.35

20.43

16.37

ACK SPLEEN CELL TREATMENT13
PHA source A (1:50)
Control

419,520.00 - 8,895.20C
14,704.35 - 885.0d
27.53

+
331,770.00 - 9,285.0
13,534.10 - 1,005.0
23.51

+
174,910.00 - 10,008
9,620.51 - 654.0
17.18

Si

A lymphocyte transformation test was performed using mouse spleen cells at three different
concentrations. Cells were plated and mitogen (PHA) was applied immediately.
Spleen cells were either subjected to ACK buffer treatment or they were left untreated,

c

Values are mean counts per minute and standard error obtained from wells containing PHA as mitogen,

d

1
Values are mean counts per minute and standard error obtained from control wells containing no mito
gen.
e

SI calculated as follows:

Mean cpm in PHA wells - Mean cpm in non- PHA wells
Mean cpm in non- PHA wells
00
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Variation in the Length of Time of Mouse Spleen Cell Exposure at Room
Temperature

A lymphocyte transformation test was performed using mouse spleen
cells (2.0 X 106 cells/ml),

Spleen cells were either subjected to ACK

buffer for lysis of red blood cells or they were left untreated.
Aliquots of 0.1 ml of spleen cells (at 2.0 X 10

cells/ml) were plated

and 0.1ml of mitogen (PHA) from one of two different sources (titrated
to either 1:50 or 1:60) was applied either immediately, at 2 hours or
4 hours after spleen cells were kept at room temperature.

Mitogen was

applied to only half of the cells in the wells of the plate whereas the
rest received 0.1 ml of RPMI-1640 medium and served as control wells.
Table X shows the results as mean counts per minute and SI values for
each of the three different time intervals.

The greater the length of time of spleen cell exposure at room
temperature the lower the counts per minute obtained for either cell
group whether subjected to ACK-buffer or not and when treated with
either source A or source B of PHA mitogen (Fig. 12)

Table X indicates that the SI values showed a similar trend. The
highest SI values were obtained immediately after the cells were plated
and lowest SI values after a 4 hour spleen cell exposure at room
temperature.

Regardless of exposure time at room temperature prior to plating.

TABLE X.
A.

EFFECTS OF TEMPERATURE ON THE RESULTS OF LYMPHOPROLIFERATION ASSAYS
NON- ACK SPLEEN CELL TREATMENT^*
Length of Time at Room Temperature
0 hrs
PHA source A (1:50)

230,500 - 9943.14C
11,160 - 456.50d

Control

19.65

SIe
PHA source B (1:60)

2 hrs
175,010 - 8667.86
9775.5 - 351.5
16.90

258,150 - 12,500C

+
228,112 - 11,029

10,907 - 1363.0d

11,030 - 1059.0

Control

22.66

19.70

4 hrs
140,130 - 9,154.00
+
8270
550
15.94
+
159,168 - 9,853.66
+
9,853 - 981.0
15.15

■L

B.

ACK SPLEEN CELL TREATMENT
PHA source A (1:50)
Control

319,000 - 13,005°

+
245,024 - 10,115

180,790 - 8,854.0

11,181 - 1265d

10,050 - 985.0

9,654 - 857.0

27.53

23.78

18.36

aA lymphocyte transformation test was performed using mouse spleen cells (2.0 X 10^'cells/ml).
Cells were plated and mitogen (PHA) was applied at three different time intervals: Immediately,
and after 2 hrs and 4 hrs at room temperature.
b
q

Spleen cells were either subjected to ACK- buffer treatment or they were left untreated.
Values are mean counts per minute and standard error obtained from wells containing PHA as mitogen.

dValues are mean counts per minute and standard error obtained from control wells containing no
mitogen.
0

SI calculated as follows:

Mean cpm in PHA wells - Mean cpm in non- PHA wells
Mean cpm in non- PHA wells

CO
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FIGURE 12. LYMPHOPROLIFERATIVE RESPONSE OF SPLEEN CELLS AFTER
APPLICATION OF PHA AT THREE DIFFERENT TIME INTERVALS: IMMEDIATELY,
AT 2 HRS. AND 4 HRS. OF CELL EXPOSURE AT ROOM TEMPERATURE. PRIOR
TO PHA STIMULATION, SPLEEN CELLS WERE EITHER SUBJECTED TO ACK BUFFER
FOR LYSIS OF RED BLOOD CELLS OR THEY WERE LEFT UNTREATED. MEAN COUNTS
PER MINUTE WERE OBTAINED FROM ACK TREATED AND NON- ACK TREATED SPLEEN
CELLS.
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spleen cells subjected to ACK-buffer gave higher counts per minute and
SI values when compared to cells that were not subjected to ACK buffer.
In addition, treatment of spleen cells with source B of PHA yielded
higher counts per minute and higher SI values than for source A.

Differences in Lymphoproliferation Assay Results with Three Different
Serum Sources

A lymphocyte transformation test was performed using three spleen
cell concentrations of 2.0 X 10

cells/ml that were prepared with

RPMI-1640 media containing serum from one of three different sources (1.
Irvine Scientific, Lot. no. 504415; 2. Irvine Scientific, Lot. no.
409717; 3. Biolabs. Lot. no. 10610).

Spleen cells were either subjected to ACK buffer treatment or they
were left untreated.

From each cell suspension, 0.1 ml aliquots were

plated and 0.1 ml of PHA mitogen from source A or source B was applied
immediately to half of the cells in the plate wells.

The rest of the

cells received RPMI-1640 medium and served as control wells.

Table XI

shows the mean counts and SI values for spleen cells in RPMI-1640 medium
containing serum from each of the three different sources.

Spleen cells that were subjected to ACK-buffer gave higher counts
per minute and

higher SI values compared to those that were not

subjected to ACK buffer.

Furthermore, treatment of spleen cells with

TABLE XI.
A.

DIFFERENCES IN LYMPHOPROLIFERATION ASSAY RESULTS USING SERUM FROM THREE DIFFERENT
SOURCES
NON - ACK SPLEEN CELL TREATMENT13
Sources of serum3
2

1
PHA source A (1:50)

258,903 - 6,081°
10,837 - 236d

12,230 - 335

Control

sie
PHA source B (1:60)

22.90

16.95

238,783 - 12,651C

196,033 - 10,658

15,771 - 852.3d

Control

14.14
B.

3

+
219,565 - 9,726

12,429 - 750
14.77

+
260,646 - 11,056
10,508 - 285
23.80
282,965 - 11,690
16,570 - 950
16.07

ACK SPLEEN CELL TREATMENT13
PHA source A (1:50)
Control

262,870 - 9,525°
14,137 - 985d
17.60

+
219,870 - 8,525

+
295,560 - 11,235

10,570 - 1,005

15,500 - 1,234

19.73

20.07

aA lymphocyte transformation test was performed using mouse spleen cells (2 .0 X 10^ cells/ml).
Spleen cells were prepared and plated immediately with RPMI-1640 media containing serum from one
of three different sources (1. Irvine Scientific, Lot no. 504415 2. Irvine Scientific,
Lot no. 409717 3. Biolabs, Lot No. 10610).
^Spleen cells were either subjected to ACK buffer treatment or they were left untreated.
c
Values are mean counts per minute and standard error obtained from wells containing PHA as mitogen.
dValues are mean counts per minute and standard error obtained from control wells containing no
mitogen,
0

SI calculated as follows:

Mean cpm in PHA wells - Mean cpm in non- PHA wells
Mean cpm in non- PHA wells

CO

4>
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source A or source B of PHA resulted in different mean counts per minute
and SI values among the three different spleen cell groups tested.
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PART III.

EXPERIMENTS DESIGNED TO IMPROVE TECHNIQUES TO BE USED
POSSIBLY IN FUTURE STUDIES

Tumor Volume Measurements Made by Two Individuals on the Same Three Mice

Tumors from three tumor-bearing male BALB/c mice were randomlymeasured ten times each by two people without them knowing which mouse
they were performing the measurements on.

These were the same two

individuals who had measured tumors on the mice fed Diet 1 and Diet 3.
One person had measured tumor volumes on mice fed Diet 1 and the other
person had measured tumor volumes on mice fed Diet 3. The results were
reported by both participants in terms of length (L), width (W), and
height (H).

Tumor volumes were calculated using the formula:

, ,3
length(L) X width(W) Xheight(H).
Tumor volume (mm) = ---------------------------------------------------------2

The measurements obtained from both individuals were statistically
analyzed and all three variables involved (length, width, height) were
compared using the analysis of variance test (Table XII).

The

non-hypothesis tested was that the compared measurements from both
individuals (length, width, height, volume) were significantly
different.

The alternative hypothesis was that the compared

measurements were statistically the same.

A

P value of

(p-^0.05)

indicated that the compared measurements were not significantly
different and the alternative hypothesis was accepted.

Length

measurements were found to have a degree of confidence of p^O.Ol
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indicating that they are not significantly different (or they are 99%
the same).

For the width measurements p 0.05 indicating a

95% confidence that the measurements were the same.

The height

measurements were found to be significantly different.

However, the

calculated volume measurements obtained from both individuals were found
to have a degree of confidence (p<0.01), indicating that these measure
ments were not significantly different or that it is reasonable to
assume that one can have confidence in the tumor volume measurements for
mice fed Diets 1 and 3 even though tumors in mice fed one diet were
measured by one person and those in mice fed the other diet were
measured by another.

Tumors in mice fed Diets 2 and 4 were measured by

only one person.

Variability in Cell Viability and Plating Efficiency among 10 Aliquots
from a Suspension of H238 Cells after Freezing at Liquid Nitrogen
Temperature.

Ten ampoules, each containing equal aliquots of 1 X 10
cells were frozen in liquid nitrogen temperature.

H238 viable

After 7 days all the

10 ampoules were removed from the liquid nitrogen storage and rapidly
thawed in a 37° waterbath.

Cells from each aliquot were reconstituted

and recounted using trypan blue as an indicator of cell viability.

The

number of viable (unstained) and dead (stained) cells, recovered from
each ampoule was recorded and the respective percentages were
calculated.

TABLE XII.

STATISTICAL ANALYSIS OF TUMOR VOLUME MEASUREMENTS

Measurements
Length

Width

Height

Volume

0.621b

0.399C

0.115d

0.633b

aTumors from three tumor-bearing BALB/c mice were randomly measured ten times each by two people.
Results were compared using the analysis of variance test.
b(Pv< 0.01).

Degree of confidence indicating that length and volume measurements are not signifi-

cantly different.

c(p^< 0.05) .

Degree of confidence indicating that width measurements are not significantly diffe-

rent.
d(p > 0.05).

Degree of confidence indicating that height measurements are probably significantly

different.

00
00

89
The calculated percentages of viable H238 cells and those of the
original cell numbers recovered, varied considerably among the 10 equal
cell aliquots.

The calculated percentages of viable cells recovered

ranged from as low as 69.2% to as high as 86.2%, while the calculated
percentages of the original cell numbers ranged from as low as 62.5% to
as high as 112.5% (Table XIII).

Cells from all ten ampoules were adjusted to an equal concentration
of viable cells, diluted at different concentrations, plated in soft
agar plates, and screened for formation of clones.

The plating of high

/

concentrations of H238 cells (1 X10

o

cells and 1 X 10

in an innumerable number of clones per plate.

cells) resulted

However, plating of 100

cells from all 10 equal aliquots, resulted in a variable number of
clones formed, averaging from 12.3 clones to 90 clones per plate well.
These results indicate that a number of H238 cells lose their viability
through the process of freezing and reconstitution and that variability
in efficiency of plating is greater than that for viability as determin
ed by trypan blue staining of the dead cells.

TABLE XIII.

VARIABILITY IN CELL VIABILITY AND PLATING EFFECIENCY AMONG 10 ALIQUOTS FROM
A SUSPENSION OF H238 CELLS AFTER FREEZING AT LIQUID NITROGEN TEMPERATURE
£

Aliquot No.

No. of cells recovered
after freezing and thawing
Unstained(V)

6

% Recovery
of viable cells

% Recovery
of original
cell numbers

% of cells
plated in^
soft agar

Stained(NV)
0.25 X 106

81.5

110

17.0

1

1.1 X 10

2

0.75 X 106

0.25 X 106

75.0

75

13.0

3

0.85 X 106

0.25 X 106

77.3

85

41.7

4

1.125 X 106

0.30 X 106

78.9

112.5

65.0

5

0.85 X 106

0.20 X 106

80.9

85

15.7

6

1.0 X io6

0.20 X 106

83.3

100

12.3

7

0.625 X 106

0.10 X io6

86.2

62.5

90.0

8

0.75 X 106

0.20 X 106

78.9

75

23.0

9

0.625 X 106

0.20 X 106

75.7

62.5

19.7

10

0.675 X 106

0.30 X 106

69.2

67.5

14.3

aThe original concentration of viable H238 cells was 1.0 X 10 /ml prior to freezing in
liquid nitrogen and kept there for 7 days.
^H238 cells were adjusted to an equal concentration of viable cells prior to plating in
soft agar.

Colonies were counted 14 days after the cells were plated,

The mean of 3 wells

containing 100 colonies or less was recorded.

o

DISCUSSION

Two of the four diets fed to the mice in this study were selected
from 14 previously used experimental diets.

The basis for their

selection was that Diet 1 (11% protein-casein, 5% fat-corn oil).
restricted tumor growth to the greatest extent in three different
mouse-tumor systems whereas Diet 4 (11% protein- wheat gluten.
30% fat-corn oil) was among those diets with which tumor growth was
least restricted (Gridley, et al., 1982,1983; Nutter et al.. 1982,
1983).

In a mouse mammary tumor study with these 14 diets (Gridley,

et al., 1983), virgin female C3H mice fed Diet 1 had the highest percent
survival at the termination of the experiment at 2 years plus six weeks.
much greater than that for mice fed Diet 4.

The fraction of mice

developing mammary tumors was also much less for Diet 1 than for Diet 4.

Since Diets 1 and 4 were different in the source of protein, in
addition to the level of fat, one purpose of the present study was to
add Diet 2 (11% protein-wheat gluten, 5% fat-corn oil) and Diet 3
(11% protein-casein, 30% fat-corn oil).

These were included as control

diets, in order to be able to determine whether the differences observed
between Diets 1 and 4, were primarily due to differences in the source
of protein or to differences in the level of fat.

However, due to

reasons previously described, mice fed Diets 1 and 3 were tested
separately (at different times) from mice fed Diets 2 and 4.

This made

it impossible to directly compare Diet 1 with Diet 2 and Diet 3 with
Diet 4.

It was possible, however, to compare Diet 1 with Diet 3
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directly and Diet 2 with Diet 4 directly.

With respect to tumor volume.

the results indicate that level of fat made a greater difference when
the source of protein was wheat gluten rather than casein.

Although one

cannot unequivocally make a statement about source of protein when the
fat level was kept constant for the reasons previously stated, there is
reason to speculate that source of protein may have had a greater effect
on tumor volume than level of fat.

Another important aspect of this study was that the diets fed were
prepared so that the ratio of individual minerals, individual vitamins.
protein and fiber to total calories remained constant as the percentage
of fat was increased.

This method was suggested by Visek and his group

(Visek and Clinton, 1983) and calls for a substitution of fat for an
equal weight of carbohydrate with adjustment of other components in
order to maintain constant nutrient to calorie ratios.

According to the

authors mice and rats determine their ad libitum intake by their caloric
needs over a wide range of fat intakes providing that the diet is
adequate in other nutrients.

The results of the weight determinations

of mice fed Diets 1 and 3 indicate that the mice gained weight at
approximately the same rate with mice fed the low fat diet and gained
slightly ahead of those on the high fat diet.

This may have occurred

because it took slightly longer for the mice fed Diet 3 to adapt to the
high fat.

The lymphoproliferation experiments dealing with changes in immune
responses with time after H238-cell injection show that cell-mediated
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immunity in tumor-bearing mice fed Diets 1 through 4 became increasingly
depressed.

Counts per minute obtained from spleen cells from mice fed

Diets 1 and 3 and stimulated with PHA, ConA or IPS were significantly
depressed at 41 days post-tumor cell injection.

From 41 days until the

time of sacrifice at 48 days post-injection, the response continued to
steadily decline.

However, counts per minute obtained from spleen cells

from mice fed Diets 2 and 4 and stimulated with either PHA, ConA or IPS
showed (after correction) an increasing pattern at 28 days post-tumor
cell injection.

However, at 49 days post tumor cell injection, the

response was much lower.

The cause(s) of the immunosuppression is/are unclear.

The

literature states that malignant transformation of a normal cell to a
tumor cell is accompanied by the appearence of tumor associated cellular
antigens.

Cells of the immune system of the host can recognize these

surface antigens as "foreign" or "non-self" and under appropriate
conditions inhibit tumor growth.

This is the basic tenet of the immune

surveillance theory proposed by Burnet (1971).

Although the importance

of the immune surveillance theory has been questioned (Kriple and Boros,
1974; Prehn, 1976, 1977), it is generally accepted as the first line of
defense against neoplastic development and growth (loachim, 1976).
However, the immune system of the host is not always able to recognize
and respond to tumor antigens (not immunologically competent) and is
often compromised by the tumor (Stites et al., 1983).
suppressive mechanisms include:

Tumor immuno-

1) serum blocking antibodies that are

specific and able to bind only to the tumor antigen but cannot bind
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complement; they are, therefore, unable to lyse the tumor cell and block
the action of other antibodies by preventing them to attach to that site
(Broder and Whitehouse, 1968); 2) soluble antigens shed by tumor cells
which react with specific antibodies to form antigen-antibody complexes
or directly block T-cell receptor sites that could otherwise react with
antigens on the tumor itself (Brooks et al., 1972; Oldstone, 1975);
3) tumor antigens can cause activation of suppressor T-lymphocytes that
respond by mediating either specific or general immmunosuppression
(Fujimoto et al., 1975; Glaser et al., 1975; Green and Fujimoto, 1977);
4) soluble tumor-released factors that mediate suppression of the host
immune response (Pennline and Evans, 1979; Havas and Schiffman, 1979;
Kumor et al., 1981a, 1981b).

Any combination of the above immuno

suppressive mechanisms could be responsible for the observed pattern of
depressed immune response as a function of time as measured in the
lymphoproproliferation assay.

A depression in spleen cell PHA, or ConA

response during progressive tumor growth has been reported by many
investigators (Gillette and Boone, 1975; Sampson et al., 1977; Erickson,
1984a, 1984b).

However, in certain systems significant depression is

observed either much earlier or much later than in the H238 cellinduced tumor system.

These differences may be attributed to factors

such as tumor growth rate, type of host species and tumor system, dose
of carcinogen and mode of tumor induction (Kamo and Friedman, 1977;
Fidler and Gerstein, 1978).

Data from our laboratories have suggested that the H238 tumor cells
release an immunosuppressive factor which either acts directly on the
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PHA or ConA responsive T-lymphocytes or induces suppressor activity in
other cell types such as macrophages or suppressor T- cells present in
the spleens of tumor-bearing mice.

This soluble factor released into

the culture medium was able to confer a state of lowered responsiveness
on effector spleen cells obtained from non-tumor bearing mice (Gridley,
Stagg, unpublished results).

There are a number of reports which

describe soluble suppressor factors elaborated by other tumor cell lines
(Plescia et al., 1975; Friedman et al., 1976).

In my experiments dealing with the effects of time on immune
responses dramatic increases in tumor volumes were seen from 3 to 5.5
weeks for mice fed Diets 1 and 3, and throughout the study (weeks 2 to
7) for mice fed Diets 2 and 4.

These great increases in tumor volumes

correlated well with the increases in relative spleen weights (RSW's)
seen from 4.5 weeks to 6 weeks for mice fed Diets 1 and 3 and from 4 to
7 weeks for mice fed Diets 2 and 4 (although mice fed Diet 2 had greater
RSW’s compared to mice fed Diet 4).

In addition, these increases in the

sizes of the spleens paralleled the decreases seen in T- cell response
to either PHA or ConA or in B- cell response to LPS.

This reaction is

known to be a function of T-cells and is often quantitated by measuring
the size or weight of the spleen.

Increase in the spleen size of tumor

bearing animals has been reported by Rowland et al., (1973), Kircher et
al., (1974), and others.

However, in some cases, only mininal

splenomegaly has been observed (Howell et al., 1975).

Nutter et al.,

(1980) using the BALB/c mouse- H238 cells animal-tumor model system
reported changes in the fractional volume of six structural components
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in the spleens of BALB/c mice during progressive tumor growth.
Specifically, the volume of the compact myeloid tissue and reaction
centers of lymphoid nodules increased about four to five-fold from 10 to
33 days after H238 tumor cell injection.

The response of spleen cells from tumor-bearing mice fed Diets 1-4
was significantly lower to IPS stimulation compared to PHA or ConA
stimulation.

This indicates that humoral immunity in the H238 tumor

system was significantly depressed following tumor-cell injection.

A

possible explanation for the suppression of humoral immunity may be the
lack of T- cell cooperation with B- cells during this time (i.e.
following H238- tumor cell injection).

Helper T-cells may either have

been inactivated or may have migrated to other sites.

That B-cell

response to LPS probably requires functional helper T-cells has been
reported by LaGrange et al., (1975) and LaGrange and Mackaness (1975).
Also, membrane structures required for LPS binding to B-cells may be
temporarily blocked by material of tumor origin, blocking antibodies or
immune complexes.

Overall, humoral response in tumor-bearing mice

varies depending on the system being studied.

It appears that tumor

growth can enhance, depress or exert no effect on lymphocyte response to
LPS (Gerny and Stiller, 1975; Gillette and Boone, 1975).

The process of carcinogenesis has been separated into at least two
steps, initiation and promotion.

A unique aspect of the tumor system

used in this study is that the possibility of diet affecting tumor
initiation has been eliminated since the H238- cells inoculated into the
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mice had already been transformed to cancer cells by the HSV Type 2
In this system, diet affects only tumor promotion.

virus.

Only a few

other diet studies have been reported in which transformed cells have
been used.

The type of protein (casein or wheat gluten) present in the diets
of mice appeared to be the most important factor influencing tumor
development.

Mice fed the 11% casein had the lowest tumor volume sizes

and relative spleen weights when the level of fat was also low (5% corn
oil) .

When a large amount of fat was present (30% corn oil) in combin-

ation with 11% casein diet, tumor volume sizes and RSW’s increased
significantly.

Thus, in casein fed mice, high fat had a tumor-

enhancing effect.

The results of the experiments dealing with the effects of protein
source and level of fat on this tumor system indicated that a low casein
fat diet has a protective effect against H238 cell-induced tumors.

A

protective effect of a diet with a moderate amount of casein (16%)
against

7, 12 dimethylbenza(a)anthracene (DMBA)-induced mammary tumors

in rats has been reported by Clinton et al., (1979, 1984).

On the other

hand, some investigators reported that diets high in casein have an
enhancing effect on certain types of tumors (Ross and Bras, 1965, 1973;
Ross et al., 1970).

Results of my experiments indicate that a likely mechanism by which
casein exerts an antitumor effect is by enhancing cell-mediated
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My data show that in the lymphoproliferation assay spleen

immunity.

cells from tumor bearing mice fed the 11% casein, low- fat diet (5% corn
oil) had significantly higher mean counts per minute when treated with
PHA, ConA or LPS mitogen compared with the 11% protein-casein, 30% fat
(corn oil).

In contrast, mice fed the 11% protein-wheat gluten, 30% fat

developed significantly greater tumor volumes throughout the study that
correlated well with the depressed lymphoproliferative response to
mitogenic stimulation, especially in the terminal stages of tumor
growth.

Tumor growth was significantly smaller in mice fed 11% wheat

gluten and 5% fat but the RSWTs were greater than those obtained from
mice fed the high fat diet.

Humoral immune responses (LPS stimulation)

were also significantly depressed compared to cell-mediated immune
responses (PHA or ConA stimulation) following tumor cell injection.

The source of dietary fat utilized in this study was corn oil, a
polyunsaturated fat.

Unsaturated fats have been shown to have a wide

spectrum of in vitro effects on the immune system; these include:
1)

depressed in vitro lymphocyte response to certain antigens and
mitogens.

2)

inhibition of neutrophil chemotactic and phagocytic function.

3)

inhibition or delay of graft-versus-host response.

4)

alteration of the lipid content of phagocytic and lymphoid cells.

5)

decreased rejection crisis in renal transplant patients (Beisel,
1981; Newberne, 1981; Locniskar et al., 1983).

Thomas and Erickson (1985) demonstrated, by using an in vivo
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system, that a high concentration of fat (particularly polyunsaturated)
in the diet suppresses T-cell responsiveness.

However, the same group

of investigators has not been able to detect any changes in the
frequency of T-cells and subsets of T-cells among the lymphocytes after
Thus, they suggested that lipids do not act

dietary fat manipulation.

by increasing or decreasing the number of T-cells or the frequency of
subpopulations or by altering the tumor cell membrane.

Instead, they

concluded, that the fatty acid effects are limited to the immuno
competent lymphocytes of the host.

Stubbs et al., (1980) reported that the lymphocyte plasma membrane
can be modified by direct addition of exogenous saturated and unsaturated fatty acids in vitro.

However, changes in the fatty acid

composition of lymphocyte plasma membranes can result in changes in
membrane fluidity (Erickson et al., 1980; Ossman, et al., 1980).

These

changes may adversely inluence the necessary events in lymphocyte
responsiveness, such as lymphocyte antigen binding.

This could result

in fewer B cells responding to antigen, lower levels of antibody
production or both (Clifford et al., 1983).

In view of this, Erickson

et al. (1983), hypothesized that responses of lymphocytes to antigens
(or mitogens) may be modified depending upon the fatty acids available
(especially polyunsaturated).

Therefore, the authors concluded, dietary

fat manipulation will change the fatty acid composition and conformation
of glycoproteins within the membrane of lymphocytes and consequently the
immune responsiveness.

In addition, Kollmorgen et al. (1979) suggested

that the absorbed dietary fat attenuates the mitogen-induced uptake of
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thymidine by lymphocytes.

The degree of attenuation was unrelated to

the degree of saturation or the chain length.

The same investigators

suggested the use of a serum-free, low-lipid medium in future
experiments, since the level of lipids in culture medium was an
influential factor in the blastogenesis of T-cells from dietary-fat
manipulated mice.

The results outlined in the preceding text show that the
lymphocytes from mice fed the low fat diets. Diets 1 and 2, consistently
exhibited a greater cell-mediated immune response to mitogenic
stimulation (PHA, ConA or IPS) compared to mice fed the high fat diets.
Diets 3 and 4.

It may be that elevated levels of dietary fat in the

plasma, a function of dietary fat intake, triggered one or more of the
mechanisms discussed above resulting in lowered immune responsiveness.

Due to the variability encountered each time the lymphoproliferation assay was performed it is difficult to make affirmative
conclusions.
investigators.

This observation is consistent with that reported by other
Oppenheim et al. (1976) indicated that a multitude of

technical as well as conceptual variables can affect the results of this
assay system.

These include the concentration of cells, the geometry of

the culture vessel, contamination of cultures with nonlymphoid cells or
microorganisms, the dose of mitogen, the incubation time of cultures.
and the techniques of harvesting the cells.

Some of the factors tested in our laboratory and found responsible
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for contributing (partially at least) to the existing variability in the
lymphoproliferation assay were:
1)

use or non-use of ACK lysing buffer in spleen cell treatment.
Treatment of spleen cells with ACK buffer and subsequent lysis of
the red blood cells resulted in higher counts per minute compared
to those that were not subjected to ACK buffer lysis.

2)

the preparation of mitogen used was also an important factor since
treatment of spleen cells with different preparations of mitogen
yielded slightly higher or lower counts per minute.

3)

plating of different spleen cell concentrations resulted in
different counts per minute.

A 20% difference between two

concentrations of spleen cells, resulted in approximately a two
fold difference in mean counts per minute obtained following
mitogenic stimulation.
4)

the length of time of mouse spleen cell exposure at room
temperature was an important variable of this assay system.

The

greater the length of time of spleen cell exposure at room
temperature, the lower the counts per minute obtained for either
cell group whether subjected to ACK buffer or not.
5)

the source of serum in the RPMI- 1640 media used for the
preparation of the lymphocytes in the lymphoproliferation assay was
another important variability factor in this assay system.
Specifically, three equivalent spleen cell concentrations
£

(2.0 X 10

cells/ml) prepared with RPMI- 1640 media containing

serum from one of three different sources resulted in different
mean counts per minute and SI values among the three different
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spleen cell groups tested.

These factors should be taken into consideration in future diet
studies or whenever the lymphocyte transformation assay is to be used.
In addition, tests other than lymphocyte transformation such as
lymphocyte cytotoxicity and macrophage function tests, would be very
useful in determining more fully the functional capacity of the immune
system in the tumor-bearing mice fed either Diets 1 and 3 or Diets 2
and 4.

In conclusion, the results in this study indicated that cellmediated immunity became increasingly depressed with time in mice
bearing H238 cell-induced tumors, while humoral immunity was sig
nificantly depressed early after tumor induction and steadily declined
until the end of the study.

Although, the four diets cannot be directly

compared because of reasons previously discussed, the type of protein
source present in the diets of the mice as well as the level of fat had
a significant effect on tumor development and immune responses.

Under

conditions of equal nutrient to calorie ratios in the preparation of the
diets, casein in the diet inhibited tumor development.

Diet 1 (low-fat.

5% corn oil) exhibited a greater cell-mediated immune response over
Diet 3 (high-fat, 30% fat).

On the other hand, presence of wheat gluten

in the diets and especially in Diet 4 (high fat-30% corn oil) resulted
in a greater depression of cell-mediated immunity while tumor growth was
greatly enhanced.

High fat used in conjunction with casein enhanced

tumor development (Diet 3), while low-fat used with wheat gluten was
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tumor-inhibiting (Diet 2).

These findings illustrate the complexity of

the relationship between dietary fat, protein source and tumorigenesis
and emphasize the need for further investigation.

Further studies should be done in order to confirm and extend the
results presented in my experiments with Diets 2 and 4.

The suppressor

factor originating from H238 cells should be further characterized and
identified, if possible.

The effects of saturated versus unsaturated

fats in our system should be further tested.

Although a number of tumor systems have been studied regarding the
immune status of the host, very few have dealt with tumors induced by
herpesvirus-transformed cells.

Since animal cells transformed by HSV

into malignant cell lines have become readily available and because the
herpesviruses are potentially oncogenic in humans, it seems likely that
much more should be done with these systems in the future.

SUMMARY

Tumor growth, spleen weights and immune responses were investigated
in BALB/c mice fed four different diets (each prepared under conditions
of equal nutrient to calorie ratios for protein and for each vitamin and
mineral), and injected with H238-tumor cells.

The indicator of cell-

mediated immunity was the counts per minute obtained in a lymphoproliferation assay by testing the spleen cells with phytohemagglutinin
(PHA) and concanavalin A (ConA) mitogens.

Humoral immunity was

determined by testing the cells with lipopolysaccharide (LPS).

Large increases in spleen weights were noted in all tumor-bearing
mice from 20 days (3 weeks) to 48 days (7 weeks) post-injection.

The

experiments dealing with changes in immune responses with time after
H238-tumor cell injection showed that cell-mediated immunity in tumor
bearing mice fed Diets 1 and 3 became increasingly depressed at 41 days
(6 weeks) post-tumor cell injection.

From 41 days to 48 days post-

injection, the response continued to decline.

However, spleen cell

counts per minute obtained from mice fed Diets 2 and 4 and stimulated
with either PHA, ConA or LPS showed (after correction) an increase at
28-days post-tumor cell injection.

However, at 49-days, the response

was much lower.

The type of protein present in the diets of mice (casein or wheat
gluten) appeared to be the most important factor influencing tumor
development.

Mice fed Diet 1 (11% casein-5% fat) had the lowest tumor

104

105
volumes and relative spleen weights (RSW's) as well as significantly
higher mean counts per minute (when treated with PHA or ConA or IPS).
However, mice fed Diet 3 (11% casein-30% corn oil) developed greater
tumor volume sizes and RSW's over a certain range.

These correlated

well with the depressed lymphoproliferative responses to mitogenic
stimulation.

In contrast, mice fed Diet 4 (11% wheat gluten-30% fat)

developed significantly greater tumor volumes throughout the study
compared to mice fed Diet 2 (11% wheat gluten-5% fat) and depressed
lymphoproliferative responses to mitogenic stimulation.

In conclusion, cell-mediated immunity was increasingly depressed
with time in mice bearing H238 cell-induced tumors, while humoral
immunity was significantly depressed soon after tumor cell injection and
steadily declined until the end of the study.

Although, the four diets

cannot be directly compared, the type of protein source present in the
diets of the mice (besides the level of fat) had a significant effect on
tumor development and immune responses.

Under conditions of equal

nutrient to calorie ratios in the preparation of the diets, casein
protein inhibited tumor development more, compared to the wheat gluten
protein.

This effect may have been due to the enhancement of cell-medi-

ated immunity in the presence of casein protein.

On the other hand.

presence of wheat gluten protein in the diets resulted in greater
depression of cell-mediated immunity and tumor enhancement.

High-fat

used in conjuction with either casein or wheat gluten enhanced tumor
development.
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APPENDIX A

DIETARY FORMULATIONS RECOMMENDED FOR USE IN A COMPLETE NUTRITIONAL DIET
FOR MICE AND RATS AND METHODS USED IN DESIGNING EQUIVALENT DIETS
CONTAINING VARYING PROTEIN SOURCES AND DIFFERENT LEVELS OF FAT.

The following calculations were made in order to prepare Diets 2
and 4.

For example, in Diet 2 (11% protein-wheat gluten, 5% corn oil) ,

analysis of wheat gluten indicated that it contained 77.8% protein.
Since Diet 2 was to contain 11% protein, the actual percentage of wheat
gluten required in Diet 2 was 14.14% (11% / 0.778).
fat (corn oil) in Diet 2 was 5%.
gluten contained 0.51% fat.
oil added in

The percentage of

The same analysis indicated that wheat

Therefore, the actual percentage of corn

Diet 2 was 5% - 0.51% = 4.49%.

The rest of the

ingredients were added based on the indicated percentages from the AIN76A semipurified rat-mouse diets (Table III).

One difference between

wheat gluten protein and casein protein was that wheat gluten protein is
deficient in two essential amino acids (lysine and threonine).
Therefore,
threonine.

Diet 2 was supplemented with 0.52% of lysine and 0.195% of
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In Diet 2 the percentages of each of the ingredients were:
wheat gluten:

14.14%

DL-methionine:

0.3% (AIN- 76A mouse Diet)

corn oil:

4.5%

AIN- 76A Vit. mixture(ours): 1.0%
AIN- 76A Min. mixture(ours): 3.5%
choline bitartrate:

0.2% (AIN- 76A mouse Diet)

celufil:

5%

lysine:

0.52%

threonine:

0.195%

Total

(AIN- 76A mouse Diet)

29.35%

The difference (100% - 29.35% = 70.65%) in Diet 2 was supplied by
carbohydrates (dextrin and sucrose).

The percentage of dextrin added in

the diet was 2/3 X 70.65 = 47.1%, while that of sucrose was 1/3 X 70.65
= 23.55%.

The 2:1 ratio of dextrin to sucrose was based on the

recommendations of Clinton et al. (1984) in lieu of the sole use of
sucrose for carbohydrate as found in the AIN— 76A diet formula.
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More complex mathematical equations were necessary to determine how
much of each ingredient was needed in the high fat diet (Diet 4).
Diet 4, 30% of fat is needed.

In

It was assumed that corn oil is 100% fat.

then 30% of corn oil was used for the preparation of Diet 4.

Next, the

amount of calories contained in 30% of fat was calculated 30 X 9 = 270
calories.

The total number of calories for Diet 2 as far as percentages

are concerned was calculated:
protein (wheat gluten):

11 X 4 = 44
5 X 9 = 45

corn oil:

0.94 X 47.10 X 4 = 177.01

dextrin:

(dextrin consists of 94% dextrin, 6% H^O)
sucrose:

23.55 X 4 = 94.2

Total calories:

360.3

Therefore, the percentage of cals from protein in Diet 4 needs to
be 44/360.3 X 100 = 12.21.

The following equations were set up:

270(fat cals)+4x(protein cals)+4y(CH0 cals)= z(total cals) Eq.[l]
But, 4x(protein cals) = 0.1221 X z(total cals)
So,

z(total cals) = 4x/0.1221

Eq.[2].

In Diet 2, DL-methionine, choline bitartrate, AIN- 76A vitamin
mixture, AIN-76A mineral mixture, celufil, lysine, and threonine
constituted 10.71% of the diet.

It was estimated for Diet 4 that this

figure will be approximately 14%.
So,

14% + 30% (fat) + x% (protein) + y% (carbohydrates)=100
x + y = 56
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y = 56 - x

Eq . [3 ]

From equations [1], [2], [3]:
270 + 4x + 4y = 4x/0.1221
4x(1-1/0.1221) + 4y + 270 = 0
4x(1-1/0.1221) + 4(56-x) + 270 = 0
4x - 4x/0.1221 + 224 - 4x + 270 = 0
4x = 0.1221 X 494
x = 0.1221 X 494/ 4
x = 15.08% protein
or: 15.08% / 0.778 = 19.38% wheat.

In Diet 4, the following percentages by weight are included:
% wheat = 19.38
%

fat

= 29.30

% others = 14.00
Total = 62.68%.
So, the percentage of carbohydrates in Diet 4 was: 100%
(12.44% sucrose, and 24.88% of dextrin),

62.68% = 37.3%

The total number of calories

for Diet 4 as far as percentages are concerned was calculated:
% protein = 15.08 X 4 = 60.32
%

fat

= 30.00 X 9 = 270.00

% dextrin = 23.39 X 4 = 93.56
% sucrose = 12.44 X 4 = 49.76
Total = 473.64
The caloric ratio between Diet 2 and Diet 4 was calculated to be:
473.64/360.3 = 1.315.

This factor was multiplied by the total
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percentage of the rest of the ingredients in Diet 2 (the percentages of
protein, fat and carbohydrates were excluded) that was previously
calculated; 1.315 X 10.715 = 14.09%.

This percentage is slightly larger

than the estimated percentage of the rest of the ingredients in Diet 4.
This, in further refining the percent calories, would reduce slightly
the calories due to added carbohydrates, making it necessary to reduce
the figure for protein slightly again.

By using this method in succes

sion several times, it was possible to design a formula for Diet 4 in
such a way that the nutrient to calorie ratios for protein as well as
all the other ingredients, other than fat and carbohydrate, were
identical to those for Diet 2.

Furthermore, Diet 4 was claimed to be an

11% protein diet, but in order to keep the nutrient to calorie ratio the
same as in Diet 2 (in this case: protein to calorie ratio) the percent
by weight of protein was, of necessity more than 11%, in this case
14.75%.

In Diets 2 and 4, the amounts of each of the ingredients contained
in the vitamin and mineral mixtures were calculated and adjusted in
order to comply with the AIN- 76A diet (vitamin 4- mineral) recommended
levels.

Sample Calculations of Ca

in Mineral Mix for Wheat Diet at 11%

Protein.

The molecular weight of dibasic calcium phosphate is: (CaHPO^):
MW = 40+1+31+64=136.

The amount of Ca

++

in AIN- 76A mineral mixture is
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40/136 = X/500.
amount of Ca
Csl^ [1].

So, X = 147.1 g/kg.

In the AIN- 76A standard diet the

is 3.5%, so 3.5/100=0.035 X 147.1 = 5.15 g/kg of
In wheat the amount of calcium is 0.358 g/kg.

So,

0.358 X 14.14/100 (% of wheat gluten in Diet 2)= 0.05g/kg [2].
amount of Ca

needed to be added in the mineral mix was:

The

5.15 - 0.05 =

5.10 g/kg.

The ratio of Ca
5.10/5.15 = 0.990.

in new mineral mix/Ca

++

in standard mix is

The amount of CaHPO. dibasic in the new mineral mix
4

for wheat diet at 11% protein was calculated to be:

0.990 X 500 g =

495.15 g/kg.

Sample Calculations of Thiamine Hydrochloride in Vitamin Mix for Wheat
Diet at 11% Protein.

Vitamin analysis of wheat protein indicated that the amount of
thiamine hydrochloride present was: 0.15 mg/100g=1.5 mg/kg.

In 14.14%

wheat gluten diet (Diet 2) there is 0.1414 X 1.5 = 0.212 mg/kg thiamine
Furthermore, there are 600mg of

hydrochloride due to wheat in Diet 2.

thiamine hydrochloride in AIN- 76A vitamin mixture.

But since only 1%

of AIN- 76A diet is vitamin mixture, 6mg/kg would be the amount of
thiamine hydrochloride in AIN- 76A.

Then, 6- 0.212 = 5.778 mg/kg needs

to be added in the new vitamin mixture.
= 0.963.

However the ratio of 5.778/6.00

Therefore, the amount of thiamine HCL necessary to be added in

the new vitamin mix was calculated to be: 0.963 X 600 mg = 578mg/kg.

AIN-76A

TABLE IA

MINERAL MIXTURE3
Amount in mixture (g/kg)

Ingredient
Calcium phosphate, dibasic
Sodium chloride
Potassium citrate, monohydrate

500.00
74.00
220.00

Potassium sulfate

52.00

Magnesium oxide

24.00

Manganous carbonate (43%-48% manganese)

3.50

Ferric citrate (16%-17% iron)

6.00

Zinc carbonate (70% zinc oxide)

1.60

Cupric carbonate (53%-55% copper)

0.30

Potassium iodate

0.01

Sodium selenite, pentahydrate

0.01

Chromic potassium sulfate, dodecahydrate

0.55

Sucrose, finely powdered
TOTAL

118.03
1,000.00

£

Committee on laboratory animal diets: P.M. Newberne, J.G. Bieri, G.M. Briggs, M.C. Nesheim.
ILAR News, Vol. XXI, Number 2(A5-A12), Winter-Spring 1978. To be used at 3.5 percent of the
diet.
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TABLE IIA

AIN-76A VITAMIN MIXTURE3

Amount (g/k.g of mixture)

Ingredient
Thiamine hydrochloride

0.6

Riboflavin

0.6

Pyridoxine hydrochloride
(Vitamin B,)

0.7

Nicotinic Acid

3.0

Calcium pantothenate

1.6

Folic Acid

0.2

Biotin

0.02

Cyanocobalamin (vit. B-12)

0.001

Retinyl palmitateC
(vit. A), premix

0.8

dl-a-Tocopherly acetate
(vit. E), premix

20.0

Cholecalciferol (vit. D^)

0.0025

Menaquionine (vit. K)6

0.05

Sucrose, finely powdered enough to make:

1,000

Committee on laboratory animal diets; P.M. Newberne, J.G. Bieri, G.M. Briggs, M.C. Nesheim.
ILAR News, Vol. XXI, Number 2 (A5-A12), Winter-Spring 1978, as modified in United States
Biochemical catalogue (1985-1986).
^Nicotinamide is equivalent.
CAs stabilized powder containing 500,000 lU/g.
or 120,000 retinol equivalents.
^As stabilized powder containing 250 lU/g.

This provides 400,000 IU vitamin A activity

This provides 5,000 IU vitamin E activity.

eMenadione
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TABLE

AIN-76A PURIFIED DIETb FOR RATS AND MICE

IIIA.

Ingredient

% of Diet

CaseinC

20.0
0.3

DL-Methionine
Cornstarch

15.0

Sucrose

50.0

Fiber^

5.0

Corn oil

5.0

AIN mineral mix

3.5

AIN vitamin mix

1.0

Choline bitartrate

0.2

aCommittee on laboratory animal diets; P.M. Newberne, J. G. Bieri, G.M. Briggs, M.C. Nesheim.
ILAR News, Vol. XXI, Number 2(A5-A12), Winter-Spring 1978.
bFrom AIN Ad Hoc

Committee on Standards for Nutritional Studies (1977) .

This diet is intended

to be used for growth and maintenance during the first year of life,
c

Feed-grade casein having at least 85 percent protein.

^Cellulose-type nonnutritive fiber.

i-1

ro
oo

APPENDIX B
LYMPHOPROLIFERATION ASSAY RESULTS ON MOUSE SPLEEN CELLS
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FIGURE IB. LYMPHOPROLIFERATIVE RESPONSE OF SPLEEN CELLS AFTER
STIMULATION WITH PHA. THE PROLIFERATIVE RESPONSE OF CELLS FROM
MICE WAS MEASURED AT VARIOUS TIME INTERVALS AFTER INJECTION OF
H238 CELLS. UPTAKE OF 3H- THYMIDINE WAS THE INDICATOR OF CELL
PROLIFERATION. THE NET COUNTS PER MINUTE (TUMOR- BEARING MICE
COUNTS PER MINUTE MINUS NON- TUMOR BEARING MICE COUNTS PER MINUTE)
OBTAINED FOR EACH OF THE DIET GROUPS (1 OR 3) ARE SHOWN.
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FIGURE 2B. LYMPHOPROLIFERATIVE RESPONSE OF SPLEEN CELLS AFTER
STIMULATION WITH CONA. THE PROLIFERATIVE RESPONSE OF CELLS FROM
MICE WAS MEASURED AT VARIOUS TIME INTERVALS AFTER INJECTION OF
H238 CELLS. UPTAKE OF 3H- THYMIDINE WAS THE INDICATOR OF CELL
PROLIFERATION. THE NET COUNTS PER MINUTE (TUMOR- BEARING MICE
COUNTS PER MINUTE MINUS NON- TUMOR BEARING MICE COUNTS PER MINUTE)
OBTAINED FOR EACH OF THE DIET GROUPS (10R 3) ARE SHOWN.
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FIGURE 3B. LYMPHOPROLIFERATIVE RESPONSE OF SPLEEN CELLS AFTER
STIMULATION WITH LPS. THE PROLIFERATIVE RESPONSE OF CELLS FROM
MICE WAS MEASURED AT VARIOUS TIME INTERVALS AFTER INJECTION OF
CELL PROLIFERATION. THE NET COUNTS PER MINUTE (TUMOR- BEARING
MICE COUNTS PER MINUTE MINUS NON- TUMOR BEARING MICE COUNTS PER
MINUTE) OBTAINED FOR EACH OF THE DIET GROUPS (1 OR 3) ARE SHOWN.
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APPENDIX C
MOUSE BODY WEIGHTS VERSUS TIME
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FIGURE 1C. MEAN WEIGHTS OF TUMOR CELL- INJECTED AND NON- INJECTED
MICE FROM 7 DAYS AFTER ARRIVAL TO EUTHANIZATION. MICE WERE FED
DIET 1 (11% CASEIN- 5% CORN OIL) OR DIET 3 (11% CASEIN- 30% CORN
OIL) RESPECTIVELY FOR A TOTAL OF 10 WEEKS PRIOR TO TUMOR CELL
INJECTION.
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FIGURE 2C. MEAN WEIGHTS OF TUMOR BEARING MICE FROM H238 TUMOR
CELL INJECTION TO EUTHANIZATION. MICE WERE FED DIET 2 (11% WHEAT
GLUTEN- 5% CORN OIL) OR DIET 4 (11% WHEAT GLUTEN- 30% CORN OIL)
FOR A TOTAL OF 20 WEEKS PRIOR TO TUMOR CELL INJECTION.
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